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ABSTRACT
Bone is a connective tissue with nanosized particles of carbonated apatitic
calcium phosphate dispersed in a hydrated collagen matrix. With the ageing of the
baby boomer population, an increasing number of people sustain bone fractures
and defects. Hence, efforts are underway to develop materials to hasten the
healing and repairing of such defects. These materials are termed as artificial bone
substitutes.
This study represents innovative techniques for development of bone
implant materials and improving the existing substitute materials. Emphasis was
on three different kinds of materials: Metals (titanium and alloys), Ceramics
(calcium phosphates), and Polymers (collagen). The bioactivity of titanium and
alloys, resorptivity of calcium phosphates and biocompatibility of collagen were
the major issues with these materials. These issues are appropriately addressed in
this dissertation. For titanium and alloys, biomimetic coating methodology was
developed for uniformly and evenly coating 3-D titanium structures. Cracks were
observed in these coatings and a protocol was developed to form crack-free
biomimetic coatings. In calcium phosphates, increasing the resorption rate of HA
(hydroxyapatite) and decreasing the resorption rate of β-TCP (β-tricalcium
phosphate) were studied. HA-based ceramics were synthesized with Na+ and
CO32- ions dopings, and development of biphasic mixtures of HA-β-TCP and HARhenanite was performed. Similarly, β-TCP ceramics were synthesized with Zn2+
ion doping and development of β-TCP-HA biphasic mixtures was performed. In
case of collagen, a biomimetic coating process was developed that decreased the
time to coat the collagen substrates and also increased biocompatibility, as
determined by the response of mouse osteoblasts.
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CHAPTER 1
INTRODUCTION
Bone graft or osteal implant surgery has been a topic of research for many
years due to ever-increasing demand for bone substitutes. An estimated 2 million
people sustain bone fractures each year in the United States as a result of activity
or trauma.1 This procedure replaces missing bone with material from either the
patient's own body (autograft), natural substitute (allograft) or a synthetic material
(artificial graft). The most desirable implants are those which are autogenous and
allogenic since no immune rejection occurs. However, sufficient material cannot
always be derived from the patient or a suitable donor and current medical
technologies are not yet able to synthesize these materials. As a consequence,
artificial materials are substituted. In contrast to the previous methods, abundant
resources are available to produce artificial replacements. In this research,
emphasis is laid on three kinds of artificial materials: Metal (Titanium and
alloys), Ceramics (calcium phosphates) and Polymer-Ceramic Composite
(collagen-calcium phosphates).
1.1

Titanium and alloys
Titanium and alloys are important materials for biomedical and dental

implants due to their lower modulus, superior biocompatibility and better
corrosion resistance when compared to more conventional stainless and cobaltbased alloys. This is due to the factor that titanium (and alloys) readily forms a
thin surface oxide layer upon contact with either air or fluids. They are generally
regarded to have good biocompatibility but are relatively bioinert, that is, they do
not bond to bone. Upon implantation, titanium (and alloys) is thereby recognized
as a foreign material and the body tries to isolate it by encasing in fibrous tissues.
The process of fibrous encapsulation is described as follows.2,3,4 After
implanted into body, neutrophils and macrophages are first noted on the implants,

followed by the formation of foreign body giant cells from activated
macrophages. It is generally accepted that osteoprogenitor cells migrate to the
implant site and differentiate into osteoblasts that make bone. After the materials
have been implanted into the body, the first stage in the reaction (after interaction
with water and ions) is non-specific protein adsorption. Afterwards, neutrophils
and macrophages interrogate the implant. The macrophage interaction and
cytokines released by the macrophages are believed to attract fibroblasts and drive
the foreign body encapsulation process.2,3,4
This leads to poor adhesion of titanium implant with the bone which is
attributed only to the mechanical interlocking of titanium surface roughness and
pores of bone. It was noted that the implant and bone is separated by a thin nonmineral layer.5 The material surface plays an extremely important role in the
response of the biological environment to the artificial implants. In order to make
titanium biologically bond to bones, surface modification methods have been
proposed to improve the bioactivity of titanium (and alloys).
Surface modifications can be performed by either physical or chemical
methods. The physical methods are used to deposit a layer of bioactive calcium
phosphates on the titanium surface. The most preferred calcium phosphate coating
that is performed is that of hydroxyapatite because of its similarity to the mineral
phase of natural hard tissues. 6-9 Current hydroxyapatite physical coating methods
can be broadly categorized as follows: (1) Plasma Spraying,10-12 (2) Dip
Coating,13-17 (3) Sputtering,18-27 (4) Electrophoretic Deposition,28-35 and (5) Pulsed
Laser Ablation36-38. Due to use of very high temperatures in most of these
processes, a change in chemical composition and structure of the hydroxyapatite
coating takes place, reducing its adhesion to the substrate, decreasing its
bioactivity, and thereby limiting its use.2 This disadvantage is overcome by using
chemical methods that are performed at relatively lower temperatures.
Current chemical modification techniques involves treating the surface
with either acid,39-42 hydrogen peroxide,43-47 or a strong base48-55 followed by a
heat treatment step which converts the layer from amorphous to crystalline. The
layer produced induces apatite forming ability on the metal surface and exhibits
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bone-bonding ability. Other common ways of chemical treatments are sol-gel
coatings,56-59 anodic oxidation,60-64 and SBF-based biomimetic coating65-69
techniques. Of these processes, only SBF-based biomimetic coatings employ
physiological conditions that is, in a solution at a pH 7.4 and 37°C, to coat. The
most important advantage is that the formed coatings retain carbonates and are
similar to the biological apatites. In a recent study it was shown that SBF-coated
titanium substrates behaved better with the osteoblast cells than alkali-treated or
pristine titanium substrates.69
The biomimetic coatings are formed by soaking an alkali pre-treated
titanium (or an alloy) substrate in a simulated body fluid (SBF) solution. The
alkali pre-treatment is a crucial step, which forms a hydrous sodium or potassium
titanate layer (depending upon the alkali used) on the substrate.68,70-72 The asformed sodium (or potassium) titanate on soaking in SBF exchanges Na+ (K+)
ions with the H3O+ ions and forms Ti-OH groups on the surface that increases the
ionic activity of apatite in SBF.73 During soaking, nanometer sized apatitic
calcium phosphate globules rapidly nucleate on the sodium (or potassium) titanate
layer and then grow to a few microns by consuming Ca and P ions from the SBF
solution.71
There are several different SBF solutions recipes available in the
literature.74-78 It was found out that different SBFs lead to different amount and
type of coating. Recently, the apatite inducing abilities of 3 different SBF
solutions referred to as c-SBF, t-SBF and r-SBF on these alkali treated titanium
substrates was investigated.69 c-74 and r-SBF75,76 are conventional and revised
versions of SBF, as developed by Kokubo. t-SBF77,78 is the formulation developed
by Tas.

The compositions of the three SBF solutions and the important

differences between them are given in ref 69. It was noted that t-SBF solutions
with an HCO3− concentration of 27mM are able to coat titanium strips more
quickly than c-SBF solutions.69 Another important conclusion from this study was
that the osteoblast response was better for coatings produced by t-SBF than r-SBF
solutions.69 These initial results were taken into consideration and a biomimetic
coating methodology was developed for uniformly and evenly coating 3-D

3

structures utilizing t-SBF (Chapter 2).
In spite of all the advantages of biomimetic coatings, it was noted that
cracks were persistently present on these apatitic calcium phosphate coatings
irrespective of the composition of the coating solution. A major consequence of
the presence of these cracks substantially increases the chances of delamination.
Thereby, decreasing the coating’s bonding ability with the natural bone. Hence,
reasons for the formation of such cracks was found and a protocol for producing
crack-free homogeneous biomimetic coating on Ti6Al4V utilizing t-SBF was
established (Chapter 3).
1.2

Calcium Phosphates
Apart from titanium and alloys, several other ceramic materials have been

discovered that have good biocompatibility. These are known as Bioceramics.
Materials that can be classified as bioceramics are: Alumina, Zirconia, Calcium
phosphates, Silica based glasses or glass ceramics, and Pyrolytic carbons.79 This
research work consists focusing on research and development of calcium
phosphate materials for implants. There are several calcium phosphates that found
use in the biomedical field and are as follows: tetra-calcium phosphate [TTCP,
Ca4(PO4)2O], tri-calcium phosphate [α-TCP, α-Ca3(PO4)2

and β-TCP, β-

Ca3(PO4)2], di-calcium phosphate anhydrous [DCPA, monetite, CaHPO4] and dicalcium phosphate dihydrate [DCPD, brushite, CaHPO4.2H2O]. However, most
commonly used calcium phosphate as substitute material is sintered HA. This is
because HA is closely similar in chemical composition, structure, and
physicochemical properties to the mineral component of the osseous tissue.80,81
Another calcium phosphate that has recently become a subject of increased
interest is sintered TCP, due to its increased resorption rate.82,83 But both these
materials experience some problems, which are highlightened in this section and
appropriate solutions are suggested.
Before proceeding further, it is important here to understand the bone
material and its remodeling process. Bone is a connective tissue with extracellular
substance consisting of a carbonated, apatitic calcium phosphate nanosize mineral
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dispersed in what is essentially a hydrated collagen matrix.84-86 All bones consist
of living cells embedded in the mineralized organic matrix, which are: the matrixforming osteoblasts, the tissue-resorbing osteoclasts, and the osteocytes.86,87
Osteoblasts are the cells present in bones which actually build the extracellular
matrix and regulate its mineralization. The lifespan of an osteoblast ranges up to 8
weeks in humans, during which time it lays down 0.5 to 1.5 prm osteoid per
day.86-88 Osteoclasts, on the other hand, are able to resorb fully mineralized bone
as they are equipped with a variety of enzymes which lower the local pH to values
between 3 and 4. Osteocytes are the principal (they account for about 90% of all
cells in the adult skeleton) cells present in adult bones, and their special
construction may actually orchestrate the spatial and temporal recruitment of the
cells that form and resorb bone. Modeling is the processes whereby bone is laid
down onto available surfaces, whereas in remodeling, osteoclastic resorption of
bone leaves pockets that are then filled by osteoblast activity.87 When the bones
no longer have any osteoblasts or osteoclasts, the modeling/remodeling processes
would cease.
Calcium phosphate-based bone substitute materials should ideally be
implanted with the design consideration that the osteoclastic resorption will be
able to slowly and gradually degrade the bone substitute material, and in the
pockets created by the osteoclasts, new bone will be deposited by the
osteoblasts.86,87 If a material is not resorbed by the osteoclasts, then it can not be
used as a bone substitute bioceramic, which can take part in bone turnover. On the
other hand, if an implant material is simply soluble in physiological fluids, then it
can not help much in the bone remodeling processes. This is due to the lack of
that precise interaction and crosstalk between the resorbing osteoclasts and
depositing osteoblasts, which must occur.86
Following observation of the behavior of bioceramics in vivo, it was determined
that the essential requirement86 for bonding of the implant is that it should:
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1. readily take part in bone remodeling ( i.e., osteoconduction the direct
anchorage of an implant by bony tissue surrounding it, without the growth of
fibrous tissue at the bone implant interface),
2. itself cause the formation of bone tissues ( i.e., osteoinduction), even if it is
not in interfacial contact with natural bones,
3. maintain its mechanical strength during the intermediate stages of cellular
(i.e., osteoclasts) active resorption, and
4. be gradually but fully replaced, within 48 to 52 weeks, by new bone (i.e.,
osseointegration) at the implantation site.
HA or β-TCP implants exhibit relatively good tissue compatibility, and new
bone is formed directly on the implants with no fibrous encapsulation.89 However,
sintered and well-crystallized HA ceramics usually demonstrated minimal in vivo
resorption, with resorption times lagging the new bone formation rates.90-94
Literature reports the lack of full participation of sintered HA implants in the bone
remodeling processes even a year after their implantation.95 Kilian et al.96 showed
that nonsintered HA could even be phagocytized and dissolved by macrophages
and osteoclasts, while sintered ceramics did not degrade and remained at the site
of implantation for years following the surgery. β-TCP, on the other hand, has a
significantly high solubility97,98 and typically fades away from the defect site even
before the completion of new bone formation. . It was shown that the dissolution
rate of β-TCP (i.e., 1.26x10-4 mol/m-2 min-1) in an aqueous solution at a pH of
about 6 was about 89 times greater than that of carbonated apatite (1.42x10-6
mol/m-2 min-1).97 As an implant the higher dissolution rate of β-TCP may result in
premature loss of mechanical strength.
An ideal skeletal repair implant should readily take part in the bone
remodeling processes, and also allow for the direct anchorage by the bony tissues
surrounding it (osteoconduction).99 If the skeletal repair implant itself causes the
in situ formation of the mineral part of the bone tissues (osteoinduction) rich in
carbonated, apatitic calcium phosphates,100 while it is continuously resorbing (in
vivo osseointegration), this could be its most effective repair method of the defect
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site.86,101-103 This is similar to the mineral phase of human bones. Loty et al.104
described the mechanism of the binding between bones and the bone-like apatite
layer. The osteoblast cells proliferate on the bone-like apatite layers, and form a
biological matrix containing apatite and collagen whilst consuming the apatite in
the bone-like apatite layer and then remodeling the layer. This bonding process
between artificial materials and natural bone is identical to that involved in the
bonding between natural bones.104 Therefore, efforts in the direction of
developing calcium phosphate-based bone substitutes of higher in vivo
resorbability and osteoinductive/osteoconductive capabilities are still needed.
Therefore, the main line of research for HA-containing biomaterials was to
increase the resorption/solubility rate of the implant material. This can be
achieved by:
(1) Preparation of nonstoichiometric HA by modification of the HA structure with
foreign ions (Na+ / K+ / Mg2+ / CO32-); and
(2) Design of poly-mineral composites incorporating HA and other calcium
phosphates.
In the first instance, resorption depends on the structural perfection of HA:
nonstoichiometry, type of solid solutions, site occupancies, and distribution of the
effective charge in the presence of foreign cations. The apatite structure is very
hospitable and allows substitutions of Ca2+, PO42- or OH- sites with other ions.79-81
There is evidence in literature that substitution results in changes in properties like
lattice parameters, morphology, and most importantly solubility without
significantly changing the hexagonal symmetry.79 Undoubtedly, HA doped with
low concentrations of select elements may promote bonding of orthopedic/dental
implants to juxtaposed bone due to its similarity with the biological apatite / bone
mineral. Therefore, our aim was first, to synthesize HA ceramics with Na+ and
CO32- ions dopings and then, to evaluate their bioactivity and biocompatibility
(Chapter 4).
As for the second line of research, a composite is formed of HA with other
calcium phosphates. The log Ksp values for all calcium phosphates is shown in
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Table 1.1. The table clearly shows that HA has the lowest dissolution rate
whereas all other calcium phosphates dissolve much faster than HA. Therefore,
making a composite of HA with other calcium phosphate will definitely improve
the resorption rate of the material in vivo. However, β-TCP has been a choice of
material since it fully resorbs in human tissue, whereas other phosphates
experience weak resorption and belong to the class of resistive compounds.
Jarcho105,106 points out that the resorption rate of implants is proportional to the
TCP content: increasing the fraction of HA reduces the resorption rate.
Other materials can also be used to make a composite. The criterion
followed in selecting these materials is that they should (1) promote bioactivity,
(2) enhance cellular proliferation, and (3) possess high solubility and increase the
degradation rate of the composite. Thus, innovative techniques were employed to
synthesize HA-TCP (Chapter 4) and HAP-Rhenanite composites (Chapter 5).
For β-TCP-containing biomaterials, the line of research followed consists of:
(1) Design of poly-mineral composites of β-TCP and HA;
(2) Stabilizing the structure of β-TCP.

Table 1.1

Solubility products of different calcium phosphates

Chemical Formula

Name

Ca/P

-log Ksp at 25ºC

Ca(H2PO4)2

MCPA

0.5

highly soluble

Ca(H2PO4)2.H2O
CaHPO4
CaHPO4.2H2O
Ca8H2(PO4)6.5H2O
α-Ca3(PO4)2

MCPM
DCPA
DCPD
OCP

0.5
1.0
1.0
1.33

highly soluble
6.90
6.59
96.6

α-TCP
β-TCP
HA,
TTCP

1.5
1.5
1.67
2.0

25.5
28.9
58.4
38.0

β-Ca3(PO4)2
Ca10(PO4)6(OH)2
Ca4(PO4)2O
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The first one is similar to that of HA, wherein composites of β-TCP and
HA are formed which lead to an optimal resorption rate and enhanced cellular
proliferation (Chapter 4). The second line of research depends on the stabilization
of the β-TCP structure. It was shown that when the β-TCP structure was
stabilized, the dissolution rate decreases, providing better mechanical properties.
This stability in structure can be achieved by substituting the larger Ca2+ (0.099
nm) ions with smaller divalent cations, such as Zn2+ (0.074 nm)107,108 or Mg2+
(0.072 nm)109 ions. Therefore, different range of Zn-doping from pure β-TCP to
1.0 wt% Zn-doped β-TCP was synthesized and we examined the effect of Zndoping on dissolution and biocompatibility (Chapter 6).
1.3

Collagen-Calcium Phosphates Composite
A composite of collagen and apatite is of special interest because of their

compositional similarity with bone.110-113 In recent years, there is an increased
effort to produce apatite-collagen composite materials by innovative biomimetic
processing.113-120 Biomimetic coating process is employed to coat collagen
substrates to synthesize the apatite-collagen composites.121-129 This process is
similar to that employed for titanium and alloys, which involves soaking the
substrate in a SBF solution, wherein several-micron-thick bioactive layers of
apatitic calcium phosphate nano-aggregates is deposited. It was noted that even
after 4 weeks of soaking time, the collagen surface was not fully covered by
apatitic calcium phosphates.122 Several modifications to the biomimetic coating
process were employed by altering the normal soaking procedures, which led to
increase in bioactivity.121-129 These methods include either changing the chemistry
of collagen or adding a compound to SBF solutions. Even after these attempted
modifications, the process appeared lengthy and the problem of the dissolution of
collagen in the liquid medium posed a relevant issue. Therefore, our aim was to
develop a biomimetically coating process that decreased the time to coat the
collagen substrates (Chapter 7).
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CHAPTER 2
OSTEOBLAST PROLIFERATION ON NEAT AND APATITE-LIKE
CALCIUM PHOSPHATE-COATED TITANIUM FOAM SCAFFOLDS
Abstract
The biocompatibility and the load-bearing ability of lightweight titanium made it
possible to be used as a biomaterial, especially in hip revision and fixation
surgery. It was initially shown that sand-blasted or surface-roughened titanium
implants had an improved bone-bonding ability over the bioinert metallic
surfaces. Plasma-spraying of a phase mixture of loosely-attached calcium
phosphates on titanium implants further improved their in vivo bone-bonding
ability. However, stoichiometric calcium hydroxyapatite ceramic of high
crystallinity is known to have poor in vivo resorbability, and is shy of taking part
in bone remodeling and of being resorbed by the osteoclasts. Supersaturated
calcium phosphate (CaP) solutions, such as synthetic body fluids (SBF), on the
other hand, are able to form “carbonated, hydrophilic and apatite-like” CaP nanoaggregates on titanium surfaces. A Tris-buffered SBF solution with an HCO3−
concentration of 27mM was used in this study. Neat, NaOH-etched, and SBFcoated (biomimetic coating) titanium foams were compared with in vitro cell
culture experiments by using rat osteoblasts. SBF-coated foams were found to
yield the highest protein concentration at the end of the in vitro culture tests. Such
biomimetic coatings were easily formed on flat strips, springs, or 3D foams of
titanium, without any geometric constraints. The coated titanium springs and
foams were characterized by using XRD, SEM, and FTIR.

(This work is published in Mater Sci Eng C 27 (2007) 432–440)

2.1.

Introduction
Human blood plasma has a Ca/P molar ratio of 2.50. On the other hand,

the same molar ratio becomes 1.556, 1.316×10−3, and 5.20 for the human
extracellular, intracellular, and cerebrospinal fluids, respectively.1 Acellular SBF
(synthetic body fluid) solutions try to mimic the ionic concentrations of human
blood plasma, therefore, SBF is supersaturated with respect to the precipitation of
carbonated, non-stoichiometric, poorly-crystallized or nanocrystalline apatite-like
calcium phosphate.2,3 Ringer's4, Earle's (EBSS, Earle's Balanced Salt Solution5)
and Hank's (HBSS6) solutions are most popular and are the guiding force for the
development of synthetic body fluid solutions of today. In contrast to the earlier
solutions, such as Ringer's, Earle's and Hanks solutions, the pH values of SBF
solutions were fixed at the physiological value of 7.4 by using organic buffers,
such as TRIS (tris-hydroxymethyl-aminomethane)2,3 or HEPES (2-(4-(2hydroxyethyl)-1-piperazinyl)ethane sulphonic acid)7–9.
c-SBF2 was essentially a TRIS–HCl-buffered variant of HBSS6. c-SBF
formulation raised the Ca/P molar ratio to 2.50, in comparison to 1.62 in HBSS.
Moreover, HBSS and c-SBF solutions have exactly the same low carbonate ion
concentrations (i.e., 4.2mM), which is far from imitating that of the human
plasma (i.e., 27mM). Tas et al.3,10 have been the first to raise the HCO3−
concentration in a TRIS–HClbuffered SBF solution (i.e., tas-SBF) to 27 mM,
while Bigi et al.7 were the first to do the same in a HEPES–NaOH-buffered SBF
solution (i.e., Bigi-SBF) of 27mM HCO3−. SBF solutions were found to be able to
induce apatite-like calcium phosphate formation on numerous metallic, ceramic or
polymeric surfaces (only after proper surface pretreatments) immersed in them.11
Oyane et al.9, who developed the HEPES-buffered r-SBF recipe with ion
concentrations exactly equal to those of human plasma, reported that r-SBF would
release CO2 gas from the fluid, causing a decrease in HCO3− concentration, and
an increase in pH value, when the storage period was long. Furthermore, these
authors stated that r-SBF would not be suitable for long-term use in the
biomimetic coating processes owing to its instability.9 The buffering agent TRIS
present in conventional SBF (c- and tas-SBF) formulations, for instance, was
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reported12 to form soluble complexes with several cations, including Ca2+, which
further reduces the concentration of free Ca2+ ions available for the real time
calcium phosphate coating. To our knowledge, this behavior has not yet been
reported for HEPES.
The term biomimetic coating stands for the formation of several micronthick layer of hydrated calcium phosphate nano-aggregates on any suitable
substrate (either metallic, ceramic or polymeric) at the human body temperature
(36.5–37°C) from a supersaturated or metastable solution, whose ionic
composition and pH value mimic those of human plasma. As implied by this
definition, the coating process shall not necessarily be instantaneous and may
progress within the long physiological timeframes as well. Calcium phosphate
deposits observed on explanted intraocular lenses13, silicon mammary
prostheses14, and heart valves and arteries15 do all form in vivo working examples
of natural biomimetic coating or calcification processes. In stark contrast to what
numerous researchers keep naming in the open literature, the calcium phosphate
aggregates deposited by the biomimetic coating processes are not simply calcium
hydroxyapatite (HA: Ca10(PO4)6(OH)2 = 3 Ca3(PO4)2·Ca(OH)2). Biomimetic
coating processes do not have the high enough pH to form a hydroxide material.
Biomimetic coating deposits contain Ca2+, HPO42−, and PO43− ions, but the Ca/P
molar ratio of those were found to be greater than 1.7, typically between 1.7 and
2.7.16 Moreover, biomimetic CaP deposits were found to lack OH− ions like the
human bones,17 and contain CO32− ions (between 19 and 40 wt.%)16.
Characteristic micro-globules or spherulites deposited by the biomimetic coating
consist of intermingling nanoplatelets of CaP resembling a porcupine architecture
with high surface area. The thickness of the formed biomimetic coating
nanoplatelets is very much comparable with that of the apatite-like nanocrystals
(20–30nm) observed in bone mineral.18 Biomimetic coating surfaces represent a
microtopographical complexity, which create a greater surface area to which bone
cell-mediated proteins could adsorb.19 Therefore, the deposits obtained by the
biomimetic coating are best described by using the following; “carbonated,
hydrated, apatite-like calcium phosphate nanoplatelet aggregates.” Characteristic
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nanotexture of such biomimetic CaP deposits on Ti6Al4V has been documented
in the open literature.20,21 Regardless of the concentration of the SBF solution
used, whether it is 1×SBF2,3 or 10×SBF21, the unique nanomorphology observed
in the deposited layers did not change. Habibovic et al.22 coated Ti6Al4V foams
(produced by polyurethane sponge-burn out method) in 3 days by using a TRISor HEPES-free 5×SBF (i.e., a solution five times more concentrated than c-SBF
recipe) solution, and reported that when the CaP-coated foams were implanted
into the back muscles of goats, they caused ectopic bone formation in 6 to 12
weeks. Tas-SBF solutions with an HCO3− concentration of 27mM are able to coat
titanium strips more quickly than c-SBF solutions23. The goal of this study was to
test the rat osteoblast attachment and proliferation on surfaces of approximately
85% porous (with interconnected pore sizes in the range of 400 to 500µm)
titanium foams. Neat, NaOH-treated (60°C, 24h) and SBF-soaked (37°C, 7 days)
titanium foam samples were prepared and the cell culture tests were performed on
those in a comparative manner. Synthetic body fluid used in this study was a
TRIS-buffered Tas-SBF solution of 27mM HCO3− concentration.
2.2.

Experimental Procedure

2.2.1. Substrate

preparation.

Titanium

foam

pieces

(Selee

Corp.,

Hendersonville, NC), with dimensions of 10×10×1.25mm, were used as substrates
in biomimetic coating. The foam pieces were washed, respectively, with acetone,
ethanol and deionized water in an ultrasonic bath, followed by immersion in
50mL of a 5M NaOH solution at 60°C for 24h in sealed glass bottles. After alkali
treatment, each foam piece was washed with an ample supply of water. In-house
Ti6Al4V springs were prepared as follows; an approximately 1-mm-thick and 7cm-long strip was first cut from a Ti6Al4V sheet, and then coiled around a steel
rod (diameter 6mm) to form the spiral/spring shape. Such spring-like samples
were used to evaluate the efficiency of the 3D surface coverage of the biomimetic
coating process.
2.2.2. SBF solution preparation. SBF solutions were prepared according to the
detailed protocol given elsewhere.3,10 The basic SBF recipe was hereby
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concentrated by 1.5 times, therefore, the solutions used in this study were named
as 1.5×Tas-SBF. Reagent-grade chemicals (all from Fisher Scientific, NJ) were
used in preparing the solutions; NaCl (>99.0%), NaHCO3 (>99.7%), KCl
(>99.5%), Na2HPO4 (>99.0%), MgCl2·6H2O (>99.5%), Na2SO4 (>99.0%),
(CH2OH)3CNH2 (>99.8%), CaCl2·2H2O (>99.5%) and HCl (37vol.%). 20mg/L
Na-azide was also added to the solutions to prevent bacteria growth. When not in
use, SBF solutions were stored in glass jars in a domestic refrigerator at 4°C.
2.2.3. Coating process. The springs or foams were soaked in 100mL of 1.5 ×
tas-SBF solutions kept at 37°C in sealed Pyrex® bottles of 100-mL capacity for a
period of 7days. SBF solutions were completely replenished with fresh solutions
every 48h. Prior to replenishment, fresh SBF solutions of pH 7.4 were heated to
37°C. At the end of 7days of soaking, samples were removed from the SBF
solutions, followed by washing first with 100mL of deionized water and then with
10mL of 98% pure ethanol.
2.2.4. Sample characterization. For phase analysis, the surfaces of the uncoated
and coated foams were investigated by an X-ray diffractometer (XRD; Model
XDS 2000, Scintag Corp., Sunnyvale, CA), operated at 40kV and 30mA with
monochromated Cu Kα radiation. The foams were also analyzed by using
Fourier-transformed infrared spectroscopy (FTIR; Nicolet 550, Thermo-Nicolet,
Woburn, MA). FTIR was equipped with an Endurance Foundation Series singlebounce diamond ATR (50° incidence angle) and 32 scans were collected at a
resolution of 4cm−1. Scanning electron microscopy (FESEM; S4700, Hitachi
Corp., Tokyo, Japan) was used to monitor the changes in the surface morphology
of the foams before and after SBF-soaking.
2.2.5. Cell culture. 7F2 rat osteoblast cells (CRL-12557, American Type Culture
Collection, Rockville, MD) were grown in 75cm2 culture flasks at 37°C and 5%
CO2 in an alpha-minimum essential medium (α-MEM, Sigma Inc.) with 2mM 1glutamine

and

1mM

sodium

pyruvate,

without

ribonucleosides

and

deoxyribonucleosides, augmented with 10% FBS. The culture medium was
changed every other day until the cells reached a confluence of 90–95%, as
determined visually with an inverted microscope. The cells then were passaged
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using trypsin (2.5 g/L)/EDTA (25mM) solution (Sigma). Obtained cells were then
seeded at a concentration of 5000cells/well on 1cm2 samples for the various
assays. Two control samples were used, one was the pristine foam and the second
was the alkali-treated foam. Cell viability was assessed after 72h, and total protein
amount was measured after 7days in a 24-well cell culture plate. Further details of
the cell culture procedures were given elsewhere.23 Cell attachment studies were
also performed on the foams by visual observation via FESEM. Prior to FESEM
investigations, cells were fixed by using 3.5% glutaraldehyde. Osteoblasts were
dehydrated through sequential washings in 50%, 75%, 95% ethanol solutions and
2 times with 100% ethanol. Samples were then critical point-dried. Samples were
sputter-coated with a thin layer of Pt prior to the FESEM observations performed
at 5kV. For statistics, all experiments were performed in triplicate, where n=3.
2.3.

Results and Discussion
The pore sizes (400 to 500µm) and strut morphology of the as-received

titanium foams were depicted in Figure 2.1a. These foams have been produced
using the polymeric sponge impregnation method with titanium powders. The
high magnification inset in Figure 2.1a showed the characteristic kinks and steps
of recrystallization phenomenon which took place during the sintering of the foam
precursors. However, the NaOH-treatment of those foams completely removed
those kinks and replaced the surface with nanoporous hydrated Na-titanate
phase(s) as shown in Figure 2.1b. Hydrated Na-titanate layers on Ti with a
slightly basic surface were believed to further enhance the biomimetic coating
process.20 SEM photomicrographs of Figure 2.2 showed that the foams were fully
covered with apatite-like calcium phosphates; consisting of micron-size CaP
globules with nanoporous surfaces. FTIR data (not shown) of the TRIS-buffered,
27mM HCO3− SBF-soaked (7 days) foam samples showed that all the coatings
consisted of carbonated (CO32− ion absorption bands seen at 1470–1420 and
875cm−1) calcium phosphates. The absence of the stretching and the vibrational
modes of the O–H group at 3571 and 639cm−1 confirmed that these coatings
might not simply be named as hydroxyapatite. We prefer to call them as
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Fig. 2.1 SEM micrographs of Ti foams prior to SBF-soaking; (a) neat surface, (b
NaOH-treated surface.
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Fig. 2.2 (a–d) SEM micrographs of 27mM HCO3-Tris-SBF-coated (7days)
titanium foams at various magnifications; characteristic CaP globules (c)
and their nano-porous texture (d) were readily visible.
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carbonated, apatite-like CaP. Micrographs of the SBF-coated titanium springs are
given in Figure 2.3.
SEM micrographs given in Figures 2.4, 2.5, and 2.6 depicted the
osteoblast proliferation and attachment on neat titanium foams, NaOH-treated
foams and the SBF-coated foams, respectively. In vitro cell culture results given
in Figure 2.7 revealed that all three groups of samples were statistically and
strikingly different from one another, and the cytotoxicity of the NaOH-treated
samples was found to be the highest (Fig. 2.7a). In the specific comparison of
pristine titanium foams with those treated in NaOH, it was evident that the former
performed much better, which meant that the surface roughness or nanotopography (or nanotexture) was not a sole factor in determining the advance of
osteoblast attachment, spreading and proliferation. Here the surface chemistry
strongly prevailed in the sense that the neat, nonporous, low surface area titanium
foams turned out to be less cytotoxic than high surface area, nano-porous, NaOHtreated foams with a surface layer of hydrated, basic Na-titanates.20
SBF-coated titanium foams, on the other hand, were found to have the
highest protein concentration and cell viability levels (Fig. 2.7). While in the case
of neat titanium foams the osteoblasts were only able to attach and then extend
their filopodia over the available surface (Figure 2.4c and d), the osteoblast cells
on SBF-coated foams were able to proliferate to the extent that even the vinculin
adhesion plaques and the actin cytoskeleton and stress fibers became visible (Fig.
2.6d). Throughout its cell culture tests, this study concurrently investigated the
same titanium foam material with three different surfaces, i.e., neat, NaOHtreated, and apatite-like CaP deposited from an SBF solution. The response of
osteoblasts to a given surface can be regarded as the sum of their ability to attach,
proliferate, and differentiate. In the attachment stage, osteoblast filopodia
explored the substrate topography (Fig. 2.4) for areas to which a greater surface
area of the cell can adhere. These filopodia were used in sensing the substrate, and
they extended over significant distances to find areas appropriate for attachment.
As was the case with NaOH treated titanium foams, cells were seen to produce
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Fig. 2.3 SEM micrographs of 27mM HCO3- Tris-SBF-coated (7 days) titanium
springs/spirals.

Fig. 2.4 Osteoblast proliferation and attachment on neat titanium foam surfaces.
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Fig. 2.5 Osteoblast proliferation and attachment on NaOH-treated titanium
foams.

Fig. 2.6 Osteoblast proliferation and attachment on 27mM HCO3-Tris-SBFcoated titanium foams.
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Fig. 2.7 In vitro (a) cell viability and (b) protein concentration histograms for the
samples of Figures 2.4–2.6.
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fewer adhesion plaques while still in the process of migration than ones
permanently settled in place (Fig. 2.5). SEM micrographs given in Figures 2.4b,
2.5b, and 2.6b alone can also be used as a concise visual comparison tool for the
osteoblast proliferation behavior on three different titanium surfaces of this study.
How does biomimetic coating proceed via SBF solutions? If a simple
aqueous solution, which only contains 2.5mM CaCl2·H2O dissolved in it, is
exposed to a gaseous CO2 atmosphere, it will start precipitating submicron
particles of CaCO3 (calcite and/or vaterite) within the following few hours of
ageing at room temperature.24 CO2 gas leads initially to the formation of carbonic
acid, H2CO3, and it will dissociate into HCO3− and CO32− aqueous species. The
reversal of these dissociation reactions will cause the release of CO2 gas out of the
solution, with an accompanied increase in the pH value. The HCO3−/CO32− pair
exerts a buffering effect. However, if one adds 27mM NaHCO3 to this Cachloride solution, this will eliminate the necessity of exposing it to a gaseous CO2
atmosphere, and again, it would only form submicron CaCO3 precipitates.25 If one
adds 1mM Na2HPO4 into the above carbonated Ca-chloride solution (Ca/P=2.50)
together with 112mM NaCl, this solution of ionic strength of 149.5mM will
precipitate carbonated calcium phosphates instead of pure CaCO3. This solution is
saturated with respect to the formation of apatite-like calcium phosphates, and it
contains Ca2+, HPO42−, HCO3−, Na+, and Cl− ions. The main question here is
whether the resultant precipitates still contain CaCO3 at their cores or not. Does
the precipitation proceed by a topotactic reaction of heavily carbonated CaP
growing on CaCO3 (vaterite perhaps) particles? These questions must be
addressed prior to calling the SBF deposited CaP layers simply as
“hydroxyapatite.” When the pH of the above solution is brought down to the
range of 5 to 6, for instance, by adding tiny droplets of dilute HCl, it will only
precipitate CaHPO4·2H2O (i.e., brushite, DCPD, dicalcium phosphate dihydrate).
If the pH value of that solution is kept at the physiological value of 7.4 or higher,
it would nucleate carbonated, apatite-like calcium phosphates. Over the pH range
of 6.2 to 10, HCO3− is the most stable carbonate species in aqueous solutions. The
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precipitation of carbonated, apatite-like calcium phosphates from such a solution
may be described by using the following reaction26:
According to the above B-type substitution scheme (which is typically
observed for low-temperature apatites) of Eq. (1), HPO42− and CO32− ions replace
the PO43− tetrahedra. The charge imbalance created by these substitutions will be
compensated by the Ca-vacancies. Monovalent Na+ ions will also substitute over
a certain fraction of the Ca-sites. Bone mineral, with extremely small sizes of
biological apatite-like crystals (i.e., 20 to 30nm), contains substantial amounts of
CO32− (4 to 6 wt.%), 0.5% Mg2+, 0.7% Na+, is about 10% Ca-deficient with the
accompanying increase in reactivity related to this condition27, and moreover, the
presence of HCO3− in aqueous environments is known to reduce the apatitic
growth rate28. As seen from Eq. (1), precipitation of apatite-like calcium
phosphates may also be accompanied by a slight pH decrease. All the precipitated
calcium phosphate powders, therefore, may possess, to a certain extent, Cadeficiency, HPO42− and CO32− ions in their nanocrystalline moieties. Carbonate
ion doping into the phosphate tetrahedra of apatite-like calcium phosphates will
result in the creation of charge compensating Ca-vacancies, and this is the reason
for the observed Ca-deficiency of CaPs synthesized in body fluids.10,29 Astala and
Stott29, based on their electron density function calculations, recently reported that
CO32− ions and the Ca-vacancies are strongly related with one another and form a
cluster complex in the crystallographic unit cell of apatite-like calcium
phosphates.
The addition of 5mM K+ and/or 0.5mM SO42− ions (since these ions are
present in the human blood plasma) into a solution as described above do not
change the nature of the precipitates formed. Increasing the amount of Na+ and
Cl− ions to the levels present in human blood plasma (i.e., 142 and 103mM,
respectively) would just increase the ionic strength of the new solution. For
instance, the ionic strength of the Tas-SBF (27mM HCO3- Tris-buffered) used in
this study is 160.5mM. Theoretically, if a solution has a low ionic strength, this
means that the ionic diffusion will be enhanced in such a solution. Therefore, in a
solution of low ionic strength and high ionic diffusion, there will be more
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nucleation sites for the precipitation reactions. CO2 would be released from an
aqueous solution at a faster rate if the solution has a low ionic strength.30 The
presence of NaCl in human blood plasma is for the purpose of fixing the ionic
strength at the value of 149.5mM. If one increases the ionic strength of an SBF
solution to above 1100mM, its rate of CO2 release would be slowed down
significantly.21 If one adds 1.5mM Mg2+ into the above solution, this would slow
down the growth rate of apatitic calcium phosphates, and also favor the formation
of poorly-crystallized (i.e., in terms of their XRD spectra—not shown here), nonstoichiometric calcium phosphates.16 Mg is, therefore, an important additive in
SBF solutions and chemically incorporated into the SBF-formed CaP
precipitates.16
Yin and Stott31 pointed out that an amorphous calcium phosphate (ACP)
precursor would always be present during the precipitation of apatite-like calcium
phosphates from highly supersaturated solutions, such as the SBF solutions used
here. Posner and Betts27 proposed that the process of ACP formation in solution
involved the formation first of Ca9(PO4)6 clusters which then aggregated
randomly to produce the larger spherical particles or globules (Figs. 2.2 and 2.6),
while the intercluster space is being filled with water. Such clusters (with a
diameter of about 0.95nm31) were the transient solution precursors to the
formation of carbonated apatite-like calcium phosphate precipitates as described
in Eq. (1) above. The passage from the angstrom-size Posner's clusters in solution
to the solid nanoaggregates of carbonated-CDHA (i.e., Ca9(PO4)5-CO3OH) or
dahllite (Ca10(PO4)6CO3=3Ca3(PO4)2·CaCO3) or a solid solution of those should
be the key concept of biomimetic coating by the use of SBF or supersaturated CaP
calcification solutions (SCS). One proton to be released by the aqueous
bicarbonate ion (i.e., HCO3−→CO32− + H+) can readily be consumed in forming
the hydrogen phosphate groups of CDHA. c-SBF solutions (which are similar to
the HBBS solution in terms of ionic concentrations) of low HCO3− concentration
(4.2mM) are slow in forming CDHA in comparison to Tas-SBF of 27mM HCO3−.
c-SBF solutions require more than 2weeks (typically 3weeks) to completely cover
a given titanium surface.2,8,11,20 If the formation of dahllite or a precursor phase
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like that is indeed required, then the sluggish response of c-SBF solutions
becomes understandable. The concentration of the carbonate ions in synthetic
body fluid formulations does significantly influence the advance of the
biomimetic coating process. Onuma and Ito32 have demonstrated, by using
dynamic light scattering, the presence of such calcium phosphate clusters from
0.7 to 1.0nm in size in transparent-looking synthetic body fluids. They reported
that calcium phosphate clusters were present in SBF even when there was no
precipitation. This was true after 5 months of storage at RT. Since these
nanoclusters are always present even in supersaturated SBF solutions, the
insertion of, for instance, a suitable alkali solution-treated titanium surface into
the solutions triggers the hexagonal packing32 of those nanoclusters to form
apatite-like CaP aggregates.
ACP can also be present together with the nanocrystalline apatite-like
CaP, as confirmed by the previous TEM studies performed on the SBF-coating
layers.33 The role of alkali-treated Ti6Al4V surfaces in stimulating the SBFcoating process has been explained in great detail by Kokubo et al.11,20
Continuation of this phase separation process from the SBF solutions will be
conditional upon the smooth supply of Ca2+, HPO42− and CO3− ions to the metalsolution interface. These colloidal precipitates (as a result of the hexagonal
packing of the nanoclusters32) are formed by a homogeneous nucleation and
precipitation process. The presence of these initial precipitates within the solution
further accelerates the coarsening of the micron-sized calcium phosphate globules
(see Figs. 2c, 3c and 6c). Precipitation observed in SBF solutions is closely
related to the HCO3− (aq) concentration. A certain fraction of dissolved carbonate
ions will be lost as CO2 (g), followed by an increase in solution pH to above 7.5,
and then this loss would decrease the level of supersaturation of the solution.34
This explains the lesser amount of coating formed on titanium surfaces when the
solutions were not replenished, let us say, for 1week. TRIS-buffered SBF
solutions (1.5SBF) of 27mM HCO3− concentration were able to form those
substratebound precipitates by the end of 2nd day of soaking at 37°C. However,
when the HCO3− concentration was lower (i.e., 4.2mM; c-SBF) in the SBF, the
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rate of formation of these precipitates is decreased. Since the Ca/P molar ratio of
the SBF solutions were 2.50, they are not stable against carbonated, apatite-like
CaP, dahllite or OCP (octacalcium phosphate; Ca8(HPO4)2(PO4)4·5H2O)
precipitation when the solution pH is higher than 6.3.16,35 On the other hand, OCP
typically forms, in comparison to CDHA, carbonated-CDHA or dahllite, at
slightly lower pH values and much lower Ca/P molar ratios36. It should be noted
that since the crystallinity of such hydrated and hydrophilic biomimetic coatings
is extremely poor, it may be rather difficult to distinguish and quantify (e.g., by
XRD) the amounts of mixed apatite-like CaP, dahllite and OCP phases in the
deposited layers.37 Dorozhkina and Dorozhkin16 determined the water and
carbonate contents of SBF-formed precipitates to be 10 and 15 wt.%, respectively.
With the advance of precipitate formation the inherent level of supersaturation in
the solution decreases, eventually the CaP nanoaggregate formation comes to a
halt, and hence this is where one would need replenishing the SBF solution. If one
does not replenish the SBF solution used in biomimetic coating for more than
several days or 1week, then due to the abovementioned loss in supersaturation
and as exemplified by Iimori et al.38, one would start seeing the deposition of
calcite (CaCO3) crystals. However, CaCO3 (nacre, aragonite, vaterite and calcite)
is one of the mostly preferred and biocompatible materials used by mother nature
in aquatic life forms.
2.4.

Conclusions
Titanium foams with interconnected pores were coated biomimetically

with apatite-like calcium phosphates in 7 days by using TRIS-buffered, 27mM
HCO3− containing 1.5×Tas-SBF solution. Titanium springs/spirals were also
coated with the same solution. Biomimetic coating process was able to cover all
the surfaces and struts of the samples. In vitro cell culture tests with rat
osteoblasts were used to compare the neat, NaOH-treated and SBF-coated
surfaces of titanium foams. In terms of osteoblast attachment, protein production
and cell proliferation, NaOH-treated surface has the least amount of cells
attached, whereas the SBF-coated surfaces had the most. Untreated, neat titanium
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foam surfaces were found to be less cytotoxic to the osteoblasts in comparison to
NaOH-treated titanium surfaces. Of the three surfaces compared, SBF-coated
surfaces exhibited the highest protein production and cell attachment figures.
Biomimetic coating is a practical and robust way of increasing the
biocompatibility of titanium foams or spring-like shapes by coating them with
bone-like, carbonated, nanotextured apatite-like calcium phosphates.
2.5.
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CHAPTER 3
A PROTOCOL TO DEVELOP CRACK-FREE BIOMIMETIC COATINGS
ON Ti6Al4V SUBSTRATES
Abstract
Biomimetic coating of titanium and related alloys with carbonated apatitic
calcium phosphate is an important area of research in implantology. One step in
the protocol involves an intermediate alkali treatment of Ti6Al4V to form a
sodium titanate layer on the alloy surface. This pre-treatment enhances the
formation of the coating from simulated body fluid (SBF) solutions. Many papers
in the biomimetic coating literature demonstrate presence of cracks in coatings,
irrespective of the SBF compositions, and placement of the substrates. The
presence of cracks may result in degradation and delamination of coatings. To the
best of our knowledge, this issue remains unresolved. Therefore, the aim of this
study was: (1) to examine and understand the reasons for cracking and (2) based
on the results, to develop a protocol for producing crack-free apatitic calcium
phosphate coatings on Ti6Al4V substrates. In this study, the authors focused their
attention to the alkali treatment procedure and the final drying step. It is
hypothesized that these two steps of the process affect the crack formation the
most. In the first case, the surfaces of alkali treated substrates were examined
with/without water soaking treatment before immersing in SBF. This water
treatment modifies the sodium titanate surface layer. In the second case, two
different drying techniques (after soaking in SBF) were employed. In one
procedure, the coated substrates were dried rapidly and in the other, they were
dried slowly. It was observed that the water treatment, irrespective of the drying
method, provides a surface, which on subsequent soaking in SBF forms a crackfree apatitic calcium phosphate coating. Based on these results, we suggest a
protocol incorporating a water soaking treatment after the alkali treatment and
prior to the SBF soaking treatment to obtain crack-free coatings.
(This work is in print in J Mater Res 22 (Jun 2007)

3.1

Introduction
Coating carbonated apatitic calcium phosphate layer on titanium and its

alloys has been of increasing interest due to their ability to directly bond with
bone.1,2 Of the many coating processes available today, the biomimetic coating
technique has many advantages including producing carbonated apatitic calcium
phosphate coatings, which is otherwise impossible to produce. The coatings are
formed by soaking an alkali pre-treated titanium (or an alloy) substrate in a
simulated body fluid (SBF) solution.3-6 The alkali pre-treatment is a crucial step,
which forms a hydrous sodium or potassium titanate layer (depending upon the
alkali used) on the substrate.3-6 The as-formed sodium (or potassium) titanate on
soaking in SBF exchanges Na+ (K+) ions with the H3O+ ions and forms Ti-OH
groups on the surface that increases the ionic activity of apatite in SBF.7 During
soaking, nanometer sized apatitic calcium phosphate globules rapidly nucleate on
the sodium (or potassium) titanate layer and then grow to a few microns by
consuming Ca and P ions from the SBF solution.4
In spite of all the advantages of the biomimetic coating process, the
phenomenon of cracking persists. Furthermore, the reason for cracking of such
coatings remains unresolved. The present paper is an attempt to examine this
issue. Previously, the present authors investigated the apatite inducing abilities of
different SBF solutions referred to as c-SBF, t-SBF and r-SBF on these alkali
treated titanium substrates.8 c-9 and r-SBF10,11 are conventional and revised
versions of SBF, as developed by Kokubo. t-SBF is the formulation developed by
Tas12,13.

The compositions of the three SBF solutions and the important

differences between them are given in ref 8. The authors noted that cracks were
persistently present on these apatitic calcium phosphate coating irrespective of the
composition of the coating solution.8 Also, the placement of the substrates (e.g.,
horizontal or vertical) was examined as a parameter affecting the formation of
cracks in the coatings.8 These cracks were present on all the substrates
irrespective of their placements.8 A major consequence of the presence of these
cracks substantially increases the chances of delamination. Thereby, decreasing
the coating’s bonding ability with the natural bone.
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The SEM micrographs, as reported by the present authors8 and other
researchers14-22 indicate that these cracks are not just surface cracks and are rather
deep. However, in the references14-20, the authors did not mention the cause of
these deep cracks. In other papers, drying is cited as a potential reason for their
formation.6,8,21,22 The main reason for this argument is that the water entrapped
does not readily escape during low temperature drying and leads to deep
cracks.6,8,21,22 It is known that in the SBF solution, Posner’s clusters are the
dominant transient phase during the formation of calcium deficient carbonated
calcium phosphates.23,24,25 Since Posner’s clusters already have water molecules
in their intercluster spaces, the aggregates of these clusters forming the nanoporous coating layers on Ti6Al4V surfaces also entrap a sizable amount of
water.23,24,25 Yet another explanation is attributed to the presence of thermal
expansion coefficient mismatch between the Ti6Al4V substrates and the calcium
phosphate coating layers.26 Most of these explanations are hypothetical in nature
and are not based on concrete experimental results.
The broad objective of the present work was to find the reasons for the
formation of such cracks and to establish a protocol for producing crack-free
homogeneous biomimetic coating on Ti6Al4V utilizing t-SBF. The reasons for
using t-SBF are given in ref. 8. Since the cracks appear to be deep, the authors
hypothesize that the hydrous sodium titanate layer4 formed on the Ti6A14V
substrate has a role in the formation of cracks in the coatings. Thus in this careful
study, we modified the pre-treatment procedure and subsequently examined its
effect on formation of cracks in the coatings. Also, we attempted new drying
procedures to examine the effect of drying on the crack formation. The rate of
removal of water differentiates the new and the conventionally used procedures.
The new procedure leads to the rapid removal of water as compared to the
conventional method, in which the entrapped water does not readily escape.
3.2

Experimental Procedure

3.2.1

Substrate Preparation and Alkali Pre-treatment. Ti6Al4V strips (Grade

5, McMaster-Carr), with the dimensions of 10 x 10 x 1 mm, were used as
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substrates in the SBF coating. The substrates were first abraded with a #100 SiC
paper (FEPA P#1000, Struers) and then washed three times respectively with
acetone, ethanol, and deionized water in an ultrasonic bath. Each substrate was
then immersed in 50 mL of 5M NaOH solution at 60ºC for 24 hours. At the end of
this alkali treatment, substrates were given two different treatments to check the
effect on change of composition of treated layer on coating cracks. The first
treatment involved the most commonly used practice of drying the substrates at
40ºC for 24 hours after alkali treatment. The second treatment consisted of
immersing the substrates in water at RT for 24 hours after the alkali treatment and
then drying them at 40ºC for 24 hours.
3.2.2

SBF Solution Preparation. The details of SBF preparation routines are

given in Table 3.1. Freshly prepared t-SBF solution12,13 was used in coating
experiments. We concentrated the basic SBF recipe by 1.5 times, as per common
practice in the biomimetic coating of Ti6Al4V. The order of addition of the
reagents to 700 mL of water is given in the second column of Table 3.1. A total of
65 mL of 1M HCl was consumed for pH adjustments during the preparation of 1 l
of 1.5 x t-SBF solution. A 15 mL aliquot of this acid solution was added just
before the addition of the sixth reagent, CaCl2.2H2O. Otherwise, the solution
would display slight turbidity. The remaining part of the HCl solution was used
during the subsequent titration. Following the addition of the eighth reagent,
tris(hydroxymethyl) aminomethane, the solution temperature was raised from

Table 3.1
Reagent
NaCl
NaHCO3
KCl
Na2HPO4⋅2H2O
MgCl2⋅6H2O
CaCl2⋅2H2O
Na2SO4
(CH2OH)3CNH2

Preparation of t-SBF solution (1 L)12,13

Weight (g)
6.547
2.268
0.373
0.178
0.305
0.368
0.071
6.057

Ion
Human Plasma(mM)
Na+
142
Cl
103
HCO327
K+
5
Mg2+
1.5
Ca2+
2.5
HPO421
SO420.5
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SBF (mM)
142
125
27
5.0
1.5
2.5
1.0
0.5

ambient temperature to 37ºC. This solution was then titrated with 1 M HCl to a
pH of 7.4 at 37ºC. During the titration process, the solution was also continuously
diluted with consecutive additions of deionised water to make the final volume
equal to 1 l.
3.2.3

Coating and Drying Process. For coating purposes, the pre-treated

substrates were soaked vertically in 100 mL of t-SBF at 37ºC in tightly sealed
Pyrex bottles of 100 mL capacity for a period of 7 days. The reason for using
vertical placement (by hanging in the solution bottle via a stainless steel wire) is
given in ref. 7. The SBF solution was replenished at every 48 hours. Prior to
replenishment, fresh SBF solutions of pH 7.4 were heated to 37ºC. The substrates
were removed from the SBF solution followed by gentle washing with
approximately 100 mL deionized water and then dried using two different
techniques. The first technique involved the commonly used method for drying
the biomimetically coated substrates that is, drying the substrates at 40 º C for 24
hours. The second technique involved water soaking, followed by rinsing with 50
mL of 99.5% ethanol and then placing the substrates at RT for 15 minutes to
evaporate ethanol.
3.2.4

Sample Characterization. For phase analysis, the surfaces of the uncoated

and coated substrates were investigated by X-Ray Diffraction (XDS 2000, Scintag
Corp., CA) using monochromated Cu Kα radiation generated at a voltage and
power of 40 kV and 30 mA, respectively. The substrates were also analyzed by
using Fourier-transformed infrared spectroscopy (Nicolet 550, Thermo-Nicolet,
MA). FTIR was equipped with an Endurance Foundation Series single-bounce
diamond ATR (50º incidence angle) and 32 scans were performed at a resolution
of 4 cm-1. In order to analyze the substrate surface, before and after every
treatment for cracks, scanning electron microscope (FESEM, S-4700, Hitachi
Corp., Tokyo, Japan) operated at 5 kV was used. To determine the amount of
sodium present in the surface layer, samples were characterized using inductively
coupled plasma-atomic emission spectroscopy (ICP-AES, Model 61E, Thermo
Electron, Madison, WI).
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3.3

Results
The results of this study are divided into two groups: a) an alkali pre-

treatment before soaking in SBF solution and b) a drying step after soaking in
SBF solution.
3.3.1

Alkali pre-treatment before soaking in SBF solution:
After the alkali treatment, substrates were divided in two sets of samples;

the first set was oven-dried at 40ºC for 24 hours and the second set was soaked in
water and then oven-dried at 40ºC for 24 hours. After completing these
procedures, the substrates were examined by XRD, FTIR, and SEM. Figure 3.1
shows the XRD patterns of (a) as-received Ti6Al4V substrates; (b) substrates
after polishing, NaOH-treatment, and drying at 40ºC for 24 hours; and (c)
substrates after polishing, NaOH-treatment, water-treatment, and then drying at
40ºC for 24 hours. Ti6Al4V readily forms titanium oxide (TiO2) layer on the
surface on exposure to air. Prior to any treatment, titanium oxide was present on
the as-received Ti6Al4V strips of this study as determined by the XRD pattern
shown in Figure 3.1a. All rutile (TiO2) peaks are marked as (*) on the pattern. A
hydrated layer of sodium titanate (marked as ^) and titanium oxide (Rutile, TiO2)
was reported to form on the exposed surfaces of Ti6Al4V strips after 24 hours of
immersion in a 5M NaOH solution at 60ºC.3,4,16 This layer was indeed found to be
present on both NaOH treated and water treated Ti6Al4V strips. Both the patterns
have similar peaks and respective intensities, and no significant difference was
found in the XRD patterns (Figs. 3.1a and b). The FTIR pattern of NaOH-treated
Ti6Al4V strips (Fig. 3.2b) shows that they were hydrated in nature with a huge
band of H2O present from 3700-2400 cm-1 and one present at 1640 cm-1. Both of
these bands were also present on the substrates after water treatment (Fig. 3.2c),
thus, confirming their hydrated nature. The most important difference in the FTIR
pattern was the presence of carbonates in the NaOH treated surface layer. FTIR
pattern showed the presence of carbonate bands (CO32-) between 1470-1410 and
at 870 cm-1 in the NaOH-treated substrates (Fig. 3.2b) whereas these bands were
absent after water treatment (Fig. 3.2c) as shown. Inductively coupled plasma
analyses showed significant differences in the amount Na present on the surface
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Fig. 3.1 XRD pattern of (a) as-received Ti6Al4V, (b) 5M NaOH treated and then
dried at 40ºC, and (c) 5M NaOH treated and then soaked in water (O:
Titanium, *: Rutile, and ^: Sodium Titanate)

Fig. 3.2 FTIR pattern of (a) as-received Ti6Al4V, (b) 5M NaOH treated and then
dried at 40ºC, and (c) 5M NaOH treated and then soaked in water
(arrows point the H2O and CO32- bands).
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layer of the NaOH treated and water treated samples. As expected during water
treatment, sodium was released from the substrate surface into the water in which
they were immersed. The amount of Na present in the hydrous sodium titanate
layer of NaOH-treated substrates was 8.25 wt.% whereas, in water treated
substrates, the amount decreased to 3.6 wt.%.
Examination of these differently treated substrates under the SEM also
showed variations in microstructure. The alkali treatment, prior to soaking in SBF
solution, provided the substrate with a certain nano-scale roughness as shown in
the SEM micrographs of Figure 3.3a. The nano-porous structure formed by the
NaOH treatment was unchanged after water treatment (Fig. 3.3b). But the water
treatment had a considerable effect on the microstructure. The NaOH-treated
substrates that were dried at 40ºC subsequently showed large number of cracks
(Fig. 3.3a), which were persistent throughout the surface of the hydrated sodium
titanate layer. These cracks might have formed during the drying process at 40ºC
due to the release of either water or carbonates from the layer. However, cracks
could not be seen in the low magnification micrographs (inset in Fig. 3.3), only in
the high magnification micrographs, they (cracks) become detectable. In contrast,
the water treated substrates were crack-free as shown in Figure 3.3b. To
summarize, it is clear that water soaking after alkali treatment forms a hydrate
sodium titanate layer without carbonates and cracks, and with a lower sodium
content. All other features remain the same.
3.3.2

Drying step after soaking in SBF solution:
This section describes the results obtained after the alkali treated

substrates (with/without water treatment) were soaked in 1.5 times t-SBF solution.
Upon soaking, calcium phosphates covered the surface of these substrates within
7 days (Fig. 3.4). The alkali treated substrates with/without water treatment after
SBF coating were dried in two different methods to see the effect of kinetics of
drying. One method was to dry the substrates by placing them at 40ºC for 24
hour; and the other was to wash the coated substrates with ethanol and then dry
them at room temperature. The former method is slower than the latter. Figure
3.4a shows that the NaOH-treated substrate coated with apatitic calcium
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Fig. 3.3 SEM micrographs of Ti6Al4V strips treated with 5M NaOH at 60ºC for
24 hours then (a) dried at 40ºC for 24 hours, and (b) soaked in deionized
water for 24 hours (inset shows low magnification view).

Fig. 3.4 Substrates after alkali treatment dried at 40ºC for 24 hours, then soaked
in t-SBF for 7 days and then (a) dried at 40ºC for 24 hours and (b) dried
with ethanol. Substrates after alkali treatment were soaked in deionized
water for 24 hours, soaked in t-SBF for 7 days, and then (c) dried at
40ºC for 24 hours, and (d) dried with ethanol (inset shows low
magnification view).
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phosphate developed deep cracks after drying it at 40ºC for 24 hours. Because
these cracks have previously been referred to as “drying cracks”, or those formed
while drying, the second method of drying was used. The SEM micrographs (Fig.
3.4b) showed morphology and cracks similar to those shown in Figure 3.4a. Thus,
this ethanol treatment was unsuccessful in removing the cracks from the coating
surface. Figure 3.4c and d show the substrates that were water treated after alkali
treatment and then soaked in SBF for 7 days. Subsequently, the substrates were
washed with water and then dried at 40ºC for 24 hours (shown in Fig. 3.4c). The
SEM micrographs at both high and low magnification (shown in inset) show a
crack-free coating surface, and also showed no significant difference in the
morphology of the apatitic calcium phosphate coatings. The micrograph depicts
the round globules with needle-like intermingled nano-size calcium phosphates on
the surface of Ti6Al4V strips. At the end of the soaking time, the substrates
(shown in Fig. 3.4d) were first washed with water and then rinsed with ethanol.
The micrograph is very similar to that in Figure 3.4c, which also shows a crackfree apatitic calcium phosphate coating.
The calcium phosphate coatings formed on substrates after different pretreatments retained a similar XRD pattern (Fig. 3.5). The broadening of the 211,
112 and 300 reflections between 30-34º and the relatively high intensity of the
002 reflection at 25.9º confirms the nano-nature and the low crystallinity of the
coatings. The titanium peaks were still visible and these are marked as (*) in the
XRD pattern (Fig. 3.5). FTIR patterns (Fig. 3.6) were also similar for all coated
samples and showed that all the coatings consisted of carbonated, (CO32- ion
absorption bands seen at 1470-1420 and 875 cm-1) calcium phosphates. The
absence of the stretching and vibrational modes of the O-H group at 3571 and 639
cm-1 confirmed that these coatings might not be simply termed as hydroxyapatite.
These characteristics are similar to the coatings that we came across in our earlier
experiments.8 Thus, the coatings retain all the expected characteristics but remain
crack-free, when soaked in water after alkali treatment.
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Fig. 3.5 XRD pattern of alkali treated Ti6Al4V soaked in 1.5x t-SBF for 7 days

Fig. 3.6 FTIR pattern of alkali treated Ti6Al4V soaked in 1.5x t-SBF for 7 days
53

3.4

Discussion
The deionized water, which normally has a neutral pH of 7.0, now has an

acidic pH of approximately 5.7 when exposed to air. Carbon dioxide dissolves
slightly in water to form carbonic acid, H2CO3, a weak acid, according to the
following reaction:
H2O + CO2 = H2CO3
When sodium hydroxide is added to this deionized water, some of it reacts with
the carbonic acid to form sodium bi-carbonate, as follows:
H2CO3 + NaOH = NaHCO3 + H2O
The pH of the solution is increased to 9. The bi-carbonate ion is relatively
unstable in comparison to the carbonate ion at this pH. Thus, it leads to the
formation of sodium carbonate, as per the following:
NaHCO3 + NaOH = Na2CO3 + H2O
Thus, the alkali solution now contains mostly NaOH with small amounts of
dissolved Na2CO3. The mechanism of the reaction of the titanium alloy with this
alkaline solution has been previously explained by Kokubo et al. 4. On soaking
the substrates in alkali solution, the negatively charged hydrated titanate forms,
with incorporated sodium ions in it.4 A hydrated layer of sodium titanate and
titanium oxide has been reported to form on the exposed surfaces of Ti6Al4V
strips after 24 hours of immersion in a 5M NaOH solution at 60ºC.3,4,16 The
formation of this hydrous sodium titanate after alkali treatment was confirmed by
the XRD pattern as shown in Figure 3.1. Since this solution contains small
amounts of Na2CO3, it also plays a role in the etching process of the Ti6Al4V
strips. There is a tendency to form either a compound containing carbonates in it
or a complex with sodium titanate on the surface layer. Although no additional
phase was detected by XRD, the presence of carbonates in the treated surface is
confirmed by FTIR pattern as shown in Figure 3.2b. To summarize, it is clear that
the surface layer of NaOH treated Ti6Al4V consists a mixture of hydrated,
carbonated sodium titanate and titanium dioxide (rutile).
One possible explanation can be presented when the alkali treated
substrates were immersed in deionized water for 24 hours at RT. The deionized
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water has a pH of 5.7, at which carbonic acid is the most stable ion phase. On
soaking the NaOH treated substrates in deionized water, there is a tendency for
the CO32- ions present in the surface layer to react with the H+ ions of water and
form carbonic acid, as follows:
2H+ + CO32- = H2CO3.
After 24 hours of soaking time, all the carbonates from the substrate surface go
through the reaction. After drying, the substrate is a carbonate-free surface. This
effect of carbonate release from the surface with water treatment is substantiated
by the FTIR pattern shown in Figure 3.2c. Thus, the data presented in this study
highlights differences in the compositions of surface layers after two different
surface treatments. The data show that the substrates, before and after water
treatment, differ in the (a) sodium, and (b) carbonate contents in the surface
treated layer.
The water soaking treatment leads to a decrease in the amount of sodium
in the alkali treated layer from 8.25 to 3.6 wt. %. In the present study, the water
treatment was performed in large amounts of water for 24 hours at RT. Though
performing the water soaking treatment with a small quantity of water at RT for 1
minute results in a decrease in the amount of sodium, it does not remove the
carbonates from the surface. Jonasova et al.17 studied the effect of washing the
alkali treated substrates with water at RT on their apatite inducing ability. No
significant difference in the rate of apatite formation was observed but the Na
amount was lowered from 9.6 to 3.5 at. %.17 When the water treatment is
performed with large amounts of water for 48 hours at 80°C, Uchida et al.27
observed an increase in apatite formation on titanium metal. However, this
enhancement of the apatite forming ability is due to the formation of anatase,
formed from the conversion of sodium titanate gel after water treatment at high
temperatures.27 The decrease in sodium content in the surface layer did not cause
this increase. Since we performed the water treatments at R.T., our results were in
direct correlation to those obtained by Jonasova et al.17. SEM micrographs in
Figure 3.4 show that the rate of apatite formation is similar on substrates with
different Na content. XRD results (Fig. 3.1) confirm that the substrate surface
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consists of rutile after water treatment at RT, instead of anatase as formed by
Uchida et al.27 after water treatment at 80°C
In studies performed by Jonasova et al.17 and Uchida et al.27, cracks were
persistently present in all the biomimetically deposited coatings. These findings
show that the presence of different sodium content in the surface layer prior to
soaking in SBF solution does not play a role in the formation of cracks in the
apatitic calcium phosphate layer. Rather, it indicates that the phases present on the
alkali treated layer are more important parameters than sodium content for
producing crack-free apatitic calcium phosphate coatings.
It is important to emphasize that the SEM micrographs (Fig. 3.4) in this
present study show significant differences in terms of crack formation on the
apatitic calcium phosphate layer. Cracks were observed on the calcium phosphate
layer deposited on the substrate containing 8.25 wt. % Na (Fig. 3.4a and 4b)
whereas none were observed after soaking in SBF on the substrate previously
containing 3.6 wt. % Na (Fig. 3.4c and 4d). The substrate surfaces both before
and after water treatment, contains sodium titanate and rutile. No other phase (eg.
anatase) was detected by the XRD. Since we rule out the possibility of the sodium
contents affecting the crack formation, we can conclude that carbonate must play
an important role in crack formation. The role of carbonates in forming cracks
initially becomes visible just after the alkali treatment. The SEM micrograph in
Figure 3.3a shows the NaOH-treated substrate without water treatment and also
demonstrates a multitude of cracks on the sodium titanate surface. This is possibly
due to the presence of (a) water, as these substrates are hydrated in nature, and (b)
carbonates, as the FTIR pattern in Figure 3.2b confirms their presence. Significant
differences are observed in the SEM micrographs after water treatment as no
cracks are seen on the sodium titanate layer (Fig. 3.3b). The FTIR pattern in
Figure 3.2c shows that the substrate is hydrated in nature and has no carbonate
bands present. Thus, the presence of cracks in the alkali treated substrates
occurring while drying is due to possible loss of carbonates as CO2 to the air.
Since no carbonates were present in the water treated Ti6Al4V strips, no cracks
were observed on the sodium titanate layer.
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These substrates with/without cracks and with/without carbonates are
soaked in SBF solution. During the final drying step, coatings with underlying
carbonated titanate phase end up cracking because the carbonates are released
from them. These cracks substantially increase the likelihood of delamination,
thereby decreasing the implant’s bonding ability to natural bones. Thus, water
soaking step is expected to improve the performance of coated Ti (or alloy)
impants.
3.5

Conclusions

This paper presents results leading to the cause of crack formation in
biomimetically coated Ti6Al4V strips. By performing carefully planned
experiments, it was found that carbonates are present in the sodium titanate layer
formed during the pre-treatment of the substrates. These carbonates during drying
tend to evaporate from the underlying surface layer as CO2 and thus, results in the
formation of deep cracks. Successful removal of carbonates from this surface
layer was performed by incorporating a water soaking treatment prior to SBF
soaking. Once the carbonates are removed, cracks cannot form during any
subsequent drying step. This paper suggests a step in the protocol, which should
be incorporated into the biomimetic coating process of titanium and related alloy
substrates, to obtain crack-free coatings.
3.6
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CHAPTER 4
IN VITRO TESTING OF CALCIUM PHOSPHATE (HA, TCP, AND
BIPHASIC HA-TCP) WHISKERS
Abstract
Calcium phosphate [single-phase hydroxyapatite (HA, Ca10(PO4)6(OH)2), singlephase tricalcium phosphate (β-TCP, Ca3(PO4)2), and biphasic HA-TCP] whiskers
were formed by starting with aqueous solutions containing NaNO3, HNO3,
Ca(NO3)2⋅4H2O and KH2PO4 (with or without urea). These solutions were
irradiated in a household microwave oven for 5 min. As-recovered precursors
were then simply stirred in water at room temperature for 1 hour to obtain the
whiskers of the desired calcium phosphate (CaP) bioceramics. Bioactivity and
biocompatibility of these whiskers were evaluated, respectively, in vitro by (1)
soaking those in synthetic body fluid (SBF) solutions at 37°C for one week, and
(2) performing cell attachment and total protein assay tests on the as-formed
whiskers by using a mouse osteoblast cell line (7F2). β-TCP, HA and HA-TCP
biphasic whiskers were all found to possess a notable apatite-inducing ability
when soaked in SBF. SBF-soaked whiskers of high nanoroughness formed a
biomimetic CaP nanotexture. Although the osteoblast viability and protein
concentrations were found to be the highest on the HA whiskers, cells were
attached and proliferated on all the whiskers.

These bioactive whiskers are

suitable to use as osteoconductive fillers in biopolymer-based hard tissue
scaffolds especially in craniofacial and maxillofacial applications.

(This work is published in J Biomed Mater Res A 78 (2006) 481–490)
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4.1.

Introduction
It is known that whiskers or fibers of many materials can be synthesized;

however, the preparation of non-toxic and biocompatible whiskers still remains as
an important task. Asbestos whiskers, for instance, which have been used for so
many decades are now known to be biohazardous and extremely carcinogenic.1
Toxicity and carcinogenic properties of SiC whiskers is well known.2-4 Therefore,
it is important to explore other whiskers that are more biocompatible. Human
body only uses the carbonated, alkali (Na+ and K+) and alkaline earth (Mg2+) iondoped, apatitic calcium phosphate as the sole inorganic, “ceramic” phase, when
and where it needs to exploit the load-bearing ability of such strong materials.
Therefore, whiskers of carbonated, apatitic calcium phosphates (CaP) are
expected to be non-toxic and perfectly compatible with the human body.5-14 CaP
whiskers were synthesized until now with the aim of using them as possible
strengthening additives for the calcium phosphate (e.g., HA: Ca10(PO4)6(OH)2)
bioceramics. Within this context, reinforcement by whiskers has been regarded as
a means of raising the fracture toughness of single-phase HA from <1 to 2-12
MPa⋅m1/2.15-17 We have recently reported18 a novel procedure which allowed to
synthesize short whiskers of either single-phase HA, single-phase TCP or
biphasic HA-TCP.
Yoshimura and coworkers1,7,9,11 laid the foundation for the hydrothermal
synthesis of hydroxyapatite whiskers and also for their use in reinforcing calcium
phosphate bioceramics.19 These hydrothermal whisker synthesis procedures,
which required aqueous solutions to be heated to 160–200°C in autoclaves, are
not suitable (owing to the increased solubility and/or hydrolysis of β-TCP phase
under such conditions) for the production of β-TCP or biphasic β-TCP-HA
whiskers.

20

Molten salt synthesis techniques, on the other hand, are suitable for

the synthesis of monodisperse β-TCP or biphasic whiskers.10
To the best of our knowledge, none of the previously synthesized calcium
phosphate whiskers has been in vitro tested by using the osteoblast cell lines.
However, until now the osteoblast attachment and proliferation have been
reported only on SiC whiskers, which were used to reinforce calcium phosphate
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self-setting cements, bioceramics or polymers.21-24 The apatite-inducing ability of
CaP whiskers,5-14, 18 when soaked in synthetic body fluid (SBF) solutions,25-27 was
also not studied or reported yet.
The present paper reports the in vitro testing of HA, TCP and biphasic
HA-TCP whiskers18 by (1) soaking them in replenished SBF solutions for one
week at 37°C, and (2) performing live/dead cytotoxicity counts, protein assay and
cell attachment tests by using mouse osteoblasts (7F2).
4.2

Experimental Procedure

4.2.1

Sample Preparation. The details of calcium phosphate whisker

preparation have been given elsewhere.18 Briefly, aqueous solutions containing
dissolved NaNO3, Ca(NO3)2⋅4H2O, KH2PO4, concentrated HNO3, and urea (all
reagent-grade, Fisher Chemicals, Fairlawn, NJ) were prepared in 10 mL of
deionized water in 30 mL-capacity Pyrex beakers, as shown in Table 4.1. The
first chemical added to the beakers was NaNO3, while the last one was urea.
Small aliquots of concentrated HNO3 were added to dissolve back any colloidal
precipitates that might have formed following the addition of Ca(NO3)2.4H2O and
KH2PO4 into the NaNO3 solution. For each case shown in Table 4.1, cleartransparent solutions were thus obtained. Sample beakers were then placed onto
10 x 10 x 1 cm3 alumina insulating fiberboards and covered with an upside down
250 mL-capacity glass beaker. To proceed with the synthesis process, the abovementioned sample assemblies were placed into a household microwave (MW)
oven (Sunbeam, max. power 600 W, 2.45 GHz, Boca Raton, FL) for only 5 min.
The MW oven was operated at its maximum power setting. At the end of 5 min of
MW heating, the sample beakers reached a temperature of about 500 to 550°C
and were slowly cooled to room temperature (RT), in the MW oven, during the
next 20 min.
The substance in the sample beaker was then placed into 500 mL of
deionized water at RT [(22 ± 1)°C] and stirred with a Teflon-coated magnetic fish
on a stirrer at around 300 rpm for 1 h, immediately followed by filtration (No. 42
filter paper, Whatman Int., Maidstone, England) in a vacuum-assisted Buechner
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Sample preparation for HA, TCP, and HA-TCP whiskers18

Table 4.1
Sample
HNO3

Ca(NO3)2⋅4H2O KH2PO4

NaNO3
(g)

HA
TCP
Biphasic

5.00
5.00
5.00

(g)

(g)

1.00
1.00
1.00

0.345
0.384
0.345

15.69 M

Urea

(mL)

(g)

0.10
0.10
0.10

Ca/P

1.75

0.075

1.67
1.50
1.67

funnel and washing with 2 L of water. The possible influence of varying the
stirring rates on whisker synthesis was not studied. At the end of filtration the
effluent solutions were transparent and free of whiskers. Samples were dried
overnight at 80°C in air.
4.2.2

Apatite-inducing ability test. Apatite-inducing ability of CaP whiskers

were tested by soaking those in a synthetic body fluid (SBF) solution. The details
of preparing these solutions were previously given elsewhere.26 Briefly, the SBF
solution we used was a tris/HCl-buffered, 27.0 mM HCO3- ion-containing
solution with the ion concentrations as given in Section 3.2.2 Table 3.1.
The distinctive characteristic of SBF solutions utilized in this study was
that they had the same carbonate ion concentration with that of human blood
plasma. In vitro tests were performed in 100 mL-capacity glass bottles, which
contained two grams of HA, TCP or biphasic HA-TCP whiskers and 90 mL of
SBF solution. Sealed bottles were kept in an oven at 37±1°C for one week.
However, after every 48 hours, the used SBF solution was replenished with a
fresh one. Recovered samples (after 1 week) were washed with an ample supply
of deionized water, followed by drying at 37°C for 48 hours in air.
4.2.3

In vitro cell culture. 7F2 mouse osteoblast cells (CRL-12557, American

Type Culture Collection, Rockville, MD) were grown on 75 cm2 culture flasks at
37ºC and 5% CO2 in alpha-minimum essential medium (MEM) with 2 mM 1glutamine

and

1mM

sodium

pyruvate,

without

ribonucleosides

deoxyribonucleosides, augmented by 10% fetal bovine serum (FBS).

28

and
The

culture medium was changed every other day until the cells reached a confluence
of 90-95%, as determined visually by using an inverted optical microscope. The
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cells were then passaged using trypsin (2.5g/L) EDTA (25mM) solution (SigmaAldrich). The obtained cells were then seeded at a concentration of 10,000
cell/well on approximately 6 mm (diameter) x 6 mm (in height) cylindrical
samples for various assays. A sintered Al2O3 disc was used as the control sample.
Cell viability assessment was performed after 72 hours and total protein amount
measurements were done after 7 days in a 96-well cell culture plate. The medium
was replenished after the first day, and then on every 48 hours during the course
of the experiments. After the prescribed time period for each test, substrates were
rinsed with phosphate-buffered saline (PBS) solution to remove any non-adherent
cells. For statistics, all experiments were performed in triplicate, where n=3.
Analysis of variance was performed using the Tukey-Kramer multiple
comparisons test.
After 72 hours, live/dead cells were counted on the samples. The
unattached cells were collected by trypsinization with 0.5 mL/well trypsin-EDTA
solution and were incubated for 10 min. The cells were collected in a conical tube,
1 mL of media was added and centrifuged for 5 min at 1000 rpm. The pellet
formed at the base was resuspended in 1 mL media. Finally, trypan blue was
added and the cells were counted under an optical microscope. Only cells that
stain blue were deemed necrotic because of plasma membrane damage.
The total protein assay was measured using BCA™ Protein Assay Kit
(Pierce Biotechnology, Rockford, IL). A working reagent (WR) was prepared by
mixing 50 parts of BCA™ Reagent A with 1 part of BCA™ Reagent B. A 200 µL
aliquot of the above-mentioned WR was added to each well and thoroughly
mixed. Following mixing, the cell culture plate was covered and incubated at
37ºC for 30 min. The absorbance at 562 nm was measured with a
spectrophotometer at room temperature. A standard curve was prepared by
plotting the average blank-corrected 562 nm measurement for BSA standard
versus its concentration in µg/mL. Protein concentration of each sample was then
determined by using this standard curve.
Osteoblast attachment and proliferation on the samples were examined by
using FESEM. Prior to FESEM investigations, cells were fixed by using 3.5%
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glutaraldehyde. The cells were dehydrated with increasing concentrations of
ethanol (50%, 75%, 90% and 100%) for 10 minutes each. Critical drying was
performed according to the previously published procedures.

20

Samples were

sputter-coated with Pt prior to the FESEM imaging at 5 kV.
All cell culture experiments were performed in triplicate and the data were
expressed as the mean of three experiments. Statistical analyses were performed
using SPSS 8.0 software (Chicago, IL). Fisher’s Least Significant Difference
(LSD) test was used at a confidence level of 95%, therefore, p values _0.05 were
considered significant.
4.2.4

Characterization. Samples were characterized by powder x-ray diffraction

(XRD) (XDS 2000, Scintag, Sunnyvale, CA), Fourier-transform infrared
spectroscopy (FTIR) (Nicolet 550, Thermo-Nicolet, Woburn, MA), field-emission
scanning electron microscopy (FESEM) (S-4700, Hitachi, Tokyo, Japan), and
inductively-coupled plasma atomic emission spectroscopy (ICP-AES) (61E,
Thermo-Jarrell Ash, Woburn, MA) analysis.
4.3

Results and Discussion
Figures 4.1a and b display the SEM morphology of the starting β-TCP

(whitlockite) whiskers used in this study. The morphology of HA and biphasic
HA-TCP whiskers were the same as reported previously.18 The biphasic whiskers
initially contained 60% TCP and 40% HA, prior to the SBF-soaking. Inductivelycoupled plasma analyses of the starting whiskers of HA, TCP and biphasic HATCP revealed that they contain around 1.5 wt% Na and 250 ppm K. With such a
presence of alkali ions, it becomes impossible to name these whiskers as fully
stoichiometric HA or TCP. The mineralized portion of human bones is not
consisting of pure Ca10(PO4)6(OH)2, it contains elements like Na+, K+, and Mg2+
up to the significant level of 1.3 wt%.15 Bone mineral is also rich in carbonate
ions, i.e., 5.8 wt% of its total weight.15
The SEM photomicrographs of Figure 4.2 depicted the unique
morphology of TCP, HA-TCP, and HA whiskers after being soaked in the SBF
solution at 37°C for one week. All of the SBF-soaked whiskers comprised
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(a)

(b)
Fig. 4.1 FESEM photomicrographs of β-TCP whiskers
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surfaces covered with carbonated apatitic calcium phosphates with a nanoscale
roughness. To the best of our knowledge, CaP whiskers (of initial composition of
either TCP, biphasic HA-TCP, or HA) with such a morphology have never been
synthesized and reported. We hereby propose to name this morphology as the
“biomimetic (SBF-grown) CaP nanotexture.” The same surface texture appears
whenever and wherever one uses an SBF solution to grow calcium phosphates
regardless of the substrate used. Biomimetic CaPs grown in an SBF solution on
Ti6Al4V strips or the CaP precipitates formed in SBF solutions always had the
same nanotexture.30
The morphology of TCP whiskers (Fig. 4.2b) soaked in SBF was
significantly different than that of HA whiskers (Fig. 4.2f), which has underwent
exactly the same treatment. TCP samples exhibited a finer, more intimately
interwoven surface, whereas in the case of HA the texture was much coarser. The
BET surface areas of all samples are reported in Table 4.2. The highest
experimental surface area value measured for the SBFsoaked TCP whiskers
corresponded very well with the highest nano-roughness / nano-texture visually
observed for these samples (compare Fig. 4.2b with Figs. 2d and 2f).
Powder X-ray diffraction and FT-IR data for the SBF-soaked whiskers are
given in Figures 4.3 and 4.4, respectively. Prior to collecting these XRD and FTIR data, the SBF-soaked whiskers (2 g in each SBF-soaking bottle) were ground
into a fine powder by using an agate mortar and a pestle. The XRD and FT-IR
data presented in Figures 4.3 and 4.4, therefore, were not limited only to the
surfaces of the whiskers. According to XRD data, TCP whiskers almost
completely transformed into apatitic calcium phosphates after one week of
soaking in the synthetic body fluid (Fig. 4.3). Since SBF solutions can only form
apatitic CaP (but not TCP), neat HA whiskers soaked in SBF solutions again
yielded characteristic HA patterns (Fig. 4.3). On the other hand, XRD peaks for
crystalline β-TCP were still visible in the SBF-soaked biphasic HA-TCP samples.
FT-IR data of Figure 4.4 revealed the presence of CO32- (1480-1420 and
873 cm-1) and HPO42- groups (870, 1133 and 1210 cm-1) in all the SBF-soaked
samples.31 Most of the time it may become somewhat difficult to distinguish
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Table 4.2

BET Surface Areas of Sample

Fig. 4.2 FESEM photomicrographs of SBF-soaked whiskers, (a) & (b): β-TCP
whiskers; (c) & (d): biphasic HA-TCP whiskers; (e) & (f): HA whiskers

69

Fig. 4.3 XRD traces of SBF-soaked whiskers (* denotes TCP peaks)

Fig. 4.4 FTIR traces of SBF-soaked whiskers
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between the resembling FT-IR spectra of β-TCP and HA, and for this purpose the
FT-IR trace of single phase β-TCP (99%, Fluka) powders is presented here in
Figure 4.5. For β-TCP, there were no absorption bands present over the range
4000 and 1300 cm-1. It is visible from Figure 4.5 that there are at least 25
absorption bands in the characteristic FT-IR trace of pure β-TCP samples
Relying on the experimental solubility values of some of the calcium phosphate
phases reported by Tang et al. 32, it is seen that the dissolution rate of β-TCP (i.e.,
1.26x10-4 mol/m-2 min-1) in an aqueous solution at a pH of about 6 is about 89
times greater than that of carbonated apatite, 1.42x10-6 mol/m-2 min-1. According
to this, it is not difficult to assume that the whiskers of TCP of this study would
dissolve in the SBF solution (in 1 week, at 37°C) at a much faster rate than those
of HA. The dissolution of TCP in aqueous solutions can be described by the
following reaction:
3Ca3(PO4)2 (s) + H2O → 9Ca2+(aq) + HPO42-(aq) + 5PO43-(aq) + OH-(aq) (1).
During the dissolution of β-TCP, the above aqueous ions combine to form
what

is

known

as

calcium-deficient

hydroxyapatite

(CDHA),

2-

33

Ca9(OH)(HPO4)(PO4)5. CDHA can also incorporate CO3 ions, and it lacks one
Ca2+ and one OH- in the unit cell of its crystal structure. CDHA yields the same
XRD pattern with that of stoichiometric hydroxyapatite, HA.
The bottom XRD trace shown in Figure 4.3, thus, belonged to the newly
formed CDHA on and along the initial TCP whiskers, until their total
consumption during the process, and this pattern was extremely difficult to
differentiate from that of HA. The original TCP whiskers, in a sense, behaved like
a “guiding scaffold” for the formation or regeneration of biomimetic CaP with a
unique rod-like morphology. The detection of HPO42- bands in the FTIR data of
Figure 4.4 also confirmed the formation of carbonated CDHA after soaking the
whiskers in SBF.34 Such non-stoichiometric, carbonated apatitic calcium
phosphates can readily accommodate a Ca/P molar ratio between 1.67 and 1.33
(i.e., octacalcium phosphate, OCP, Ca8H2(PO4)6⋅5H2O). OCP is an acidic calcium
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Fig. 4.5 FTIR trace of pure β-TCP powders
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phosphate salt, and the formation of it in neutral aqueous solutions of pH 7.4
(such as SBF) is extremely difficult, if not impossible. The strongest XRD
reflection for the OCP phase is to be detected at d-spacing = 18.703 Å, however,
the XRD data of the SBF-soaked whiskers of this study did not exhibit this peak.
SBF solutions are supersaturated with respect to apatitic calcium
phosphate nucleation due to their high Ca/P molar ratio of 2.5, and therefore, even
when they are optically transparent, they contain calcium phosphate clusters with
sizes around 10 Å. 35 These CaP clusters were first described by Betts and Posner
et al.36 to have the Ca9(PO4)6 stoichiometry, and are now known as Posner
clusters. These clusters present in the SBF solutions aggregate to produce the
biomimetic CaP nanotexture, while filling the intercluster spaces with water and
bicarbonate molecules. Dorozhkina and Dorozhkin37 quantitatively confirmed the
carbonated nature of such clusters when they reached the micron-size range.
Dissolution of β-TCP provided the SBF solution, at the dissolution
interface, with the aqueous ions given in equation (1), and the presence of these
ions triggered the hexagonal packing of Posner clusters35 of the SBF to form
carbonated, nano-textured, apatitic calcium phosphates on the whiskers [Figs.
4.2a and b). When HA was present as a phase in those whiskers (since it had a
significantly lower solubility in comparison to β-TCP), the supply of those ions to
the solution was slowed down. This was why the XRD traces (Fig. 4.3) of
biphasic HA-TCP still contained peaks of β-TCP. In the case of pure HA
whiskers (Figs. 4.2e and f), the formation of the biomimetic CaP nanotexture was
much more incomplete as compared to those of β-TCP whiskers (Figs. 4.2a and
b), due to their almost two order of magnitude lower solubility. As expected,
biphasic HA-TCP whiskers had taken an intermediate place in between the pure
TCP and pure HA samples, in terms of forming that interlocking, intermingling
biomimetic CaP nanotexture.
The characteristic surface morphology of the neatwhisker cylinders (6 mm
x 6 mm) on which the osteoblast cells were cultured is given in the SEM
micrograph of Figure 4.6. As a result of the pressing action, whiskers formed a
porous compact while maintaining their individual shapes. Mouse osteoblast cells
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(7F2) cultured on whisker samples (as is, not soaked in SBF) exhibited
differences in terms of the number of attached cells and protein concentration, as
presented in Figures 4.7a & b. The number of attached cells and the measured
protein concentrations were found to yield the highest values for HA whiskers.
The results of the Fisher’s least significant difference (LSD) test are
shown in Table 4.3. LSD test is basically a student’s t test using a pooled error
variance, and is suitable for making pair-wise comparisons among a set of t
population means. In Table 4.3, p values less than 0.05 indicated that there was a
statistically meaningful and reliable difference. In other words, the cell attachment
and protein concentrations registered for the Al2O3 control samples were
statistically different than those of all the CaPs of this study.
At the significance level of 0.05, when TCP was compared with HA in
terms of cell attachment and total protein concentration, the p values for both LSD
tests came out to be less than 0.05 (as shown in Table 4.3). Therefore, we are 95%
confident that there is a difference in cell viability and total protein concentration
between HA and TCP whisker compacts. However, it was not possible to detect
any statistical difference between HA-TCP and TCP or HA-TCP and HA in terms
of number of cells attached and protein concentration.
Osteoblast attachment and proliferation on the surfaces of whisker
samples was monitored by SEM, and given in Figures 4.8a through f. Osteoblasts
were attached to the surfaces of all the whisker samples tested here, however, the
high-magnification pictures showed significant differences in osteoblast
proliferation.
Osteoblast behavior is sensitive to the biochemical and topographical features
(i.e., chemical and physical microarchitecture) of their substrate. The ideal and
most preferred surface used by osteoblasts in vivo is the osteoclast resorption
pits.38 The cell attachment and the protein assay histograms given in Figures 4.7a
and 4.7b clearly showed that the CaP whiskers always performed better than the
control samples of sintered, dense Al2O3. Mouse osteoblasts were able to easily
differentiate between the chemical compositions of the CaP whiskers. In other
words, osteoblasts favored whiskers of hydroxyapatite (HA) those of over β-TCP
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Fig. 4.6 FESEM micrograph of the surface of whisker cylinders used in cell
culture tests.

Table 4.3 p Values for the Number of Cells Attached and Protein Concentration
Test
No. of
Cells
Attached
Total
Protein
Conc.

Control
HA
HA-TCP
TCP
Control
HA
HA-TCP
TCP

Control
0.001*
0.006*
0.019*
0*
0*
0*

HA
0.001*
0.143
0.041*
0
0.159
0.019*
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HA-TCP
0.006*
0.143
0.441
0*
0.159
0.202

TCP
0.019*
0.041*
0.441
0*
0.019*
0.202
-

(a)

(b)
Fig. 4.7 (a) Number of attached cells on whiskers (control: Al2O3) and (b)
Protein assays for whiskers (control: Al2O3)
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Fig. 4.8 FESEM photomicrographs of osteoblast proliferation on whiskers, (a) &
(b): β-TCP whiskers; (c) & (d): biphasic HA-TCP whiskers; (e) & (f):
HA whiskers
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or biphasic HA-TCP. It is a well-known fact that the surface chemistry of a
material determines the initial in vitro interactions of proteins, such as fibronectin
with integrin cell-binding domains, which in turn regulate the cell adhesion
process. Osteoblast response to the CaP surfaces of this study can be regarded as
the sum of their ability to attach, proliferate, and differentiate. In the attachment
stage, osteoblast filopodia explore the substrate topography for areas to which a
greater surface area of the cell can adhere. These filopodia are used in sensing the
substrate, and they extend over significant distances to find areas appropriate for
attachment.39 All of the FESEM micrographs of Figure 4.8 revealed the readily
extension of those filopodia.
On whisker surfaces, cells were flattened and spread with clear actin fibers
associated with vinculin adhesion plaques (Fig. 4.8). For instance, the FESEM
micrograph of Figures 4.8a and b, recorded on the surfaces of β-TCP whiskers,
clearly showed the actin cytoskeleton and the stress fibers. On the other hand, the
micrographs of Fig. 4.8d and f displayed the vinculin adhesion plaque formation
on the biphasic HA-TCP and HA whiskers, respectively.
Cells are known to produce fewer adhesion plaques while still in the
process of migration than once permanently settled in place.40 Sun et al.41 exposed
cells to calcium phosphate particles and reported that HA particles (100 nm) or βTCP particles (100 nm) inhibited the growth of primary mouse osteoblasts, while
causing an increase in their expression of alkaline phosphatase.42 In addition,
Pioletti et al.43 observed a decrease in growth, viability, and synthesis of
extracellular matrix (ECM) in primary mouse osteoblasts that were exposed to βTCP particles (1–10 µm) or CaHPO4⋅2H2O particles (1–10 µm). A 90% decrease
in viability was reported by Pioletti et al.43 when evaluated using a Live-Dead
assay similar to what we have used in this study. Our results with the β-TCP
whiskers also confirmed the findings of Pioletti et al.43 The bone depositing cells,
i.e., osteoblasts, always prefer more basic surfaces to attach and proliferate, and
this was also confirmed in the present study. The basicity of the whiskers
increased in going from β-TCP (neutral pH) to HA (pH> 9). The pH values of assynthesized whiskers were measured, at 37°C, by inserting a pH electrode into
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suspensions prepared by adding 1 g of whiskers into 5 mL deionized water, and
after keeping the whiskers in these for 15 min.
CaP particles and other bioactive materials have been used as fillers in
polymer-based bone cements to improve their mechanical properties.44-47 Besides
calcium phosphates, SiC whiskers were also used as fillers, for instance, to
reinforce Bis-GMA-based dental resins to extend their use to large load-bearing
restorations.20 The SiC whiskers possessed a high structural perfection resulting in
superior strength values. While plain whiskers did not significantly strengthen the
resin matrix, nano-silica attachment (on the whiskers) was reported48 to roughen
the whisker surfaces and enhanced whisker retention in the matrix, resulting in
strong composites with substantially increased strength and toughness.
Nevertheless, even calcium carbide “ceramic” particles are not resorbable in vivo,
and their cytotoxicity behavior, in case they go into the bloodstream of a patient
and possibly end up in kidneys and/or liver are not known at all.49
The SBF-soaked β-TCP, biphasic HA-TCP, and HA whiskers reported in
this study have a very high nanoscale surface roughness, and they are fully
biocompatible with the human body. These novel whisker scaffolds will speak to
the hypotheses recently developed by Webster et al.28,29 on the extraordinary
bioactivity behavior observed on the surfaces of otherwise bioinert materials, such
as Al2O3, ZrO2, or metallic alloys, when they possess some degree of nanoscale
roughness. Our research on the incorporation of these SBF-soaked whiskers
having a “biomimetic CaP nanotexture” into biopolymers, such as cross-linked
gelatin or alginates, is in progress, which we plan to report in due time. These
biopolymer-CaP composites will be utilized in craniofacial and maxillofacial
surgery.
4.4.
1.

Conclusions
Whiskers of bioactive β-TCP, biphasic HA-TCP and HA have been
synthesized by using a simple microwave-assisted molten salt synthesis
procedure.18 This procedure readily allowed for the on demand synthesis of
any of these whiskers.
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2.

When soaked in synthetic body fluid (SBF) solutions for 1 week at 37°C, all
of the whiskers were found to form carbonated, apatitic calcium phosphates,
while still retaining their whisker form.

3.

After SBF-soaking a unique “biomimetic CaP nanotexture” was observed on
the surfaces, which imparted to the whiskers a nanoscale surface roughness.

4.

In vitro cell culture tests performed with the mouse osteoblasts (7F2) on the
whiskers showed increasing cell attachment and protein concentration rates
in the following order: HA > biphasic HA-TCP > β-TCP.

4.5
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CHAPTER 5
A NEW RHENANITE (β-NaCaPO4) AND HYDROXYAPATITE BIPHASIC
BIOMATERIAL FOR SKELETAL REPAIR
Abstract
Biphasic

β-rhenanite

(β-NaCaPO4)–hydroxyapatite

(Ca10(PO4)6(OH)2)

biomaterials were prepared by using a one-pot, solution-based synthesis
procedure at the physiological pH of 7.4, followed by low-temperature (300–
600°C) calcination in air for 6 h. Calcination was for the sole purpose of
crystallization. An aqueous solution of Ca(NO3)2.4H2O was rapidly added to a
solution of Na2HPO4 and NaHCO3, followed by immediate removal of gel-like,
poorly-crystallized precursor precipitates from the mother liquors of pH 7.4.
Freeze-dried precursors were found to be nanosize with an average particle size of
45 nm and a surface area of 128m2/g. Upon calcination in air, precursor powders
crystallized into biphasic (60% HA–40% rhenanite) biomaterials, while retaining
their submicron particle sizes and high surface areas. β-rhenanite is a high
solubility sodium calcium phosphate phase. Samples were characterized by XRD,
FTIR, SEM, TEM, ICP-AES, TG, DTA, DSC, and surface area measurements.

(This work is published in J Biomed Mater Res Part B 80 (2007) 304–316)

5.1.

Introduction
In orthopedic, oral and maxillofacial surgery, a variety of synthetic bone

grafts have been used to fill skeletal defects originating from tumor resection,
trauma, or infection.1–3 Synthetic calcium phosphates, such as calcium
hydroxyapatite [HA; Ca10(PO4)6(OH)2], β-tricalcium phosphate [β-TCP; β Ca3(PO4)2] and biphasic mixtures of these two have found use as bone
substitutes.4–6 HA or β-TCP implants exhibit relatively good tissue compatibility,
and new bone is formed directly on the implants with no fibrous encapsulation.7
However, sintered and well-crystallized HA ceramics usually demonstrated
minimal in vivo resorption, with resorption times lagging the new bone formation
rates.8–12 Kilian et al.

13

showed that nonsintered HA could even be phagocytized

and dissolved by macrophages and osteoclasts, while sintered ceramics were not
degraded and remained at the site of implantation for years following the surgery.
β-TCP, on the other hand, has a significantly high solubility14,15 and typically
fades away from the defect site even before the

completion of new bone

formation. An ideal skeletal repair implant should readily take part in the bone
remodeling processes, and also allow for the direct anchorage by the bony tissues
surrounding it (osteoconduction).16 If the skeletal repair implant itself causes the
in situ formation of the mineral part of the bone tissues (osteoinduction) rich in
carbonated, apatitic calcium phosphates,17 while it is continuously resorbing (in
vivo osseointegration), this could be its most affirmative contribution to the defect
site.18–21 Therefore, efforts in the direction of developing calcium phosphatebased

bone

substitutes

of

higher

in

vivo

resorbability

and

osteoinductive/osteoconductive capabilities are still needed.
In stark contrast to sintered HA ceramics,10,11 calcium phosphate (CaP)
self-setting cement formulations, which intentionally employed poorlycrystallized apatite as their major powder component, were shown22–24 to have
significant in vivo resorbability (i.e., with resorption rates in excess of 98% in 26
weeks following the implantation in the case of, for instance, α-BSM™, Etex,
Cambridge, MA). These cements rapidly took part in the bone remodeling
processes by going through phagocytosis under the action of macrophages and
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osteoclasts.22 Besides these special orthopedic cements, such high resorption rates
with calcium phosphates have only been encountered when the tested (in vivo)
materials comprised nanoapatites.25
Bone is a connective tissue with extracellular substance consisting of a
carbonated, apatitic calcium phosphate nanosize mineral dispersed in what is
essentially a hydrated collagen matrix. The mineral portion comprises two
intimately mixed calcium phosphate phases; (i) noncrystalline or amorphous
calcium phosphate and (ii) a poorly-crystallized apatitic calcium phosphate. In the
formation of bone mineral, the amorphous phase is laid down first by the bonedepositing cells, i.e., osteoblasts, and subsequently a significant portion of this is
then converted in the physiological environment to the carbonated, Na-, K-, and
Mg-doped, Ca-deficient bioapatite during the in vivo maturation of bones.26 The
presence of the noncrystalline calcium phosphate phase in bones has been
detected even by the very first electron microscope studies.27 The earlier work of
Posner and coworkers28–35 set the foundation for the synthesis and
characterization of amorphous or poorly-crystallized calcium phosphate powders.
The cytoplasmic calcium phosphate mineral was found to have a structure built up
of close-packed ion clusters of about 10 Å similar to those of Ca9(PO4)6 present in
synthetic amorphous calcium phosphates. Short-range order existed in these
amorphous clusters (i.e., Posner clusters) but no long-range order was detected as
crystalline hydroxyapatites have.35 The work of Eanes and coworkers36–43 and
Rey and coworkers24,44–52 on the preparation of poorly-crystallized calcium
phosphates should also be cited in this context.
β-Rhenanite (β-NaCaPO4) is an alkali calcium orthophosphate, which was
recently shown to support cellular proliferation together with expression of
osteogenic markers at a level higher than β-TCP,53 and NaCaPO4 was, therefore,
suggested to possess a higher potency to enhance osteogenesis than β-TCP.
Ramselaar and coworkers54–57 were the first to investigate the biodegradation rate
of NaCaPO4 implants in direct comparison to HA and β-TCP from six weeks to
three months in vivo. Knabe et al.58 noted the remarkably high solubility (1.0 g
per liter of H2O at pH 7.54) of NaCaPO4 samples in a comparative set of in vitro
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rat bone marrow cell culture tests performed on a number of calcium phosphates.
Suchanek et al.59 discovered the formation of NaCaPO4 interphase layers of high
biocompatibility during the hot pressing of hydroxyapatite and bioactive glass
powders together. Glass ceramics which contained NaCaPO4 as the crystalline
phase were also reported to be bioactive.60–62
On the other hand, “Rhenania process” is a well-known procedure mostly
used in the fertilizer industry to obtain a soluble phosphate material.63 In this
process, the natural mineral of hydroxyapatite is mixed with Na2CO3 and SiO2
whereas the molar ratio of Na2CO3/P2O5 fixed at 1.0. SiO2 is added to prevent the
occurrence of free CaO in the sintered product. These powder mixtures are then
ground together and calcined in a rotary kiln at about 1000–1200°C for about few
hours. Rhenanite, NaCaPO4, of high solubility, has been the major phase in the
final product of the Rhenania process.63 As could be expected, NaCaPO4 received
such a high-temperature treatment has a rather low surface area, low surface
reactivity, and larger powder particles.
Resorbable, granular bone graft substitutes based on NaCaPO4
formulations have already been commercialized and marketed for the orthopedic
surgeons.64,65 Self-setting cements based on NaCaPO4 are also available for the
repair of bone defects.66 Nevertheless, the powders of such products have been
produced by high-temperature (>1100°C) processes.64
The motivation for the present study stems from our interest in developing
a robust synthesis route for the manufacture of biphasic nanopowders of
NaCaPO4 and carbonated, apatitic calcium phosphate using temperatures less than
700°C. Specifically, the apatitic calcium phosphate powders are known to lose
their carbonate ions when and if a temperature higher than 700°C was used.67 The
soluble component of these biphasic mixtures (i.e., NaCaPO4), under the in vivo
action of osteoclasts, is assumed to supply Ca2+ ions, as well as hydrogenated
phosphate ions, to the surrounding tissues upon implantation. Such materials can,
therefore, be expected to act like an osteoinductive stimulant in the body.
Therefore, our experimental approach to that end was framed around the
following straightforward supposition: “amorphous or poorly-crystallized calcium
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phosphate powders are known to consist of nanoparticles of apatitic calcium
phosphates,24 and if those powders were synthesized at the physiological pH in
the presence of a rather significant amount of Na+ ions, then upon calcining those
powders over the temperature range of 300–600°C, the resultant material should
be a biphasic powder mixture of NaCaPO4 and apatitic calcium phosphate with a
high surface area.” This work, to the best of the knowledge of authors, reports for
the first time the aqueous preparation of nanosize calcium phosphate precursor
powders, which are able to readily transform into biphasic powder mixtures of βNaCaPO4 and carbonated hydroxyapatite upon low-temperature calcination.
5.2.

Experimental Procedure

5.2.1

Synthesis of Calcium Phosphate Powder Samples. The synthesis method

used to form the Na-containing poorly-crystallized apatitic calcium phosphate
powders simply consisted of preparing two solutions, and the procedure adapted
here was inspired by the work of Lee et al.68 Solution-A was prepared as follows;
86.4 g Na2HPO4 (disodium hydrogen phosphate, >99%, Fisher Scientific,
Fairlawn, NJ) was dissolved in 1.2 L of deionized water, followed by the addition
of 60.0 g NaHCO3 (sodium hydrogen carbonate or sodium bicarbonate, >99%,
Fisher), which resulted in a clear solution with a pH of about 9 at RT (22 ± 1°C).
Solution-B was prepared by dissolving 70.0 g of Ca(NO3)2.4H2O (calcium nitrate
tetrahydrate, >99%, Fisher) in 500 mL of deionized water. Solution-B was then
rapidly added into solution-A under constant stirring (at 250 rpm, with a 5 cm
long, Tefloncoated magnetic fish) at room temperature. The pH of the resultant
milky suspension (with a nominal Ca/P molar ratio of 0.49) was then rapidly
raised to around 7.4, i.e., the physiological pH value, by adding 3 – 5 mL

of

concentrated NaOH solution. The solids were immediately filtered by using a
filter paper (No. 42, Whatman International, Maidstone, UK) placed in a vacuumsuction porcelain Buechner funnel assembly, and washed with 4 L of deionized
water. Upon filtering and washing the

precipitates in the funnel one obtains a

gel-like calcium phosphate precipitate body (i.e., CaP gel). Some portion of the
recovered gels was placed in a glass Petri dish and dried at 37°C for 72 h in static
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air in a drying oven, while the remainder of the sample was first frozen at -80°C
for 2 h, and then lyophilized in a vacuum chamber (Freezone® 4.5, Labconco,
Kansas City, MO) kept at 5 x 10-2 mbar at RT overnight. The above-mentioned
synthesis recipe has been repeated six times, and the reproducibility in the
composition of precursor powders was checked by consecutive triplicate chemical
analyses.
To test the influence of solution pH on the phase composition of the
resultant precipitates, in a number of experiments the pH of Solution-A was first
decreased to 4.2 at room temperature, under vigorous stirring, by slowly adding
aliquots of concentrated HNO3 (69.2%, Fisher Scientific, Fair Lawn, NJ). The pH
value of Solution-B was also reduced to 4.2 by adding HNO3, followed by adding
Solution-B into Solution-A rapidly, as described above. The precipitates were
then immediately filtered out of the mother liquor in a fashion similar to that
mentioned above.
CaP powders obtained at pH 7.4 placed in clean aluminum oxide crucibles
or boats were calcined in a static air atmosphere in an electrically-heated muffle
furnace (5°C/min heating and cooling rates) over the temperature range of 300–
600°C, with 6 h of soak time at the peak temperatures. Calcined samples were
lightly ground (only for few minutes) in an agate mortar by using an agate pestle.
To test the sinterability of these rhenanite–HA biphasic samples, we have
uniaxially pressed (5000 kg/cm2) eight pellets (each 1.5 mm thick) out of the
600°C-calcined biphasic powders. These pellets were then separately heated in an
electrical resistance, chamber furnace to 1000°C at the rate of 5°C/min, held at
that temperature for 6 h, and then cooled back to room temperature within the
furnace either at the rate of 5°C/min or 1°C/min.
5.2.2

Powder Characterization. Samples were characterized, at all stages, by

powder X-ray diffraction (XRD Model XDS 2000, Scintag, Sunnyvale, CA),
scanning electron microscopy (SEM, Model S-4700, Hitachi, Tokyo, Japan),
transmission electron microscopy (TEM, Model HD200, Hitachi), Fouriertransform infrared spectroscopy (FTIR, Model Nicolet 550, Thermo-Nicolet,
Woburn, MA), inductively-coupled plasma atomic emission spectroscopy (ICP-
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AES, Model 61E, Thermo Jarrell Ash, Woburn, MA), thermogravimetry
(TG/DTA, Model 851e, Mettler-Toledo, Columbus, OH) and differential scanning
calorimetry (DSC, Model SDT 2960, TA Instruments, New Castle, DE) analyses,
and surface area measurements (Model ASAP 2020, Micromeritics, Norcross,
GA).
Powder samples for XRD analyses were first ground in an agate mortar
using an agate pestle and then sprinkled onto ethanol-damped single crystal quartz
sample holders as a thin and flat layer, followed by tapping to remove the excess
of powder. The X-ray diffractometer was operated at 40 kV and 30 mA with
monochromated Cu Kα radiation. XRD data were collected in the step mode over
the 2θ range of 3°–50°, with a scanning speed corresponding to 0.01° per minute.
FTIR samples were first ground in a mortar, in a manner similar to that used in
the preparation of XRD samples, and then placed onto the diamond ATR holder
of the FTIR spectrometer. This spectrometer was equipped with an Endurance
Foundation Series single-bounce diamond ATR (50° incidence angle), and 32
scans were performed at a resolution of 4 cm-1. Powder samples examined with
the scanning electron microscope (SEM) were sputter-coated with a thin Pt layer,
just prior to imaging, to improve the conductivity of samples. For the transmission
electron microscope (TEM) investigations, small aliquots of respective powder
samples were first dispersed in pure ethanol, and then few drops of those
suspensions were dried on the sample holder grids. The BET surface area of
powder samples was determined by applying the standard Brunnauer–Emmet–
Teller method to the nitrogen adsorption isotherm obtained at -196°C using the
Micromeritics ASAP 2020 instrument. Powder samples used in the ICP-AES
analyses were first dissolved in nitric acid prior to measurements. For carbon
analyses, 200 mg of powder samples was combusted at around 1200°C in oxygen
atmosphere by using a C analyzer (Model Vario Macro, Elementar, Mt. Laurel,
NJ). In this process, carbonaceous moieties were converted into CO2, and after
catalytic post-oxidation, drying, and cleaning of carrier gas, all carbon oxides are
reduced to molecular carbon over a reducing agent and transported by the carrier
gas to the thermoconductivity cell for the final quantitative determination of
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carbon content. Carbon content was then reported by the computer of the
instrument as wt % C present in the samples. We converted the measured C
contents into CO3 percentages. Thermogravimetric analyses (TGA) of the CaP gel
(or powder) samples were performed in Pt crucibles in a static air atmosphere
with a heating rate of 5°C/min from RT to 800°C. Water content of the precursor
powders were directly deduced from the TGA traces. DTA and DSC runs were
also performed in Pt crucibles in flowing air atmosphere with a heating rate of
5°C/min, and Al2O3 powder was used as the reference sample in these
experiments.
5.3

Results and Discussion
The synthesis procedure described in Synthesis of Calcium Phosphate

Powder Samples was able to produce apatitic calcium phosphate powders when
the synthesis solution pH was maintained at 7.4. The results and data given below
are all for pH 7.4 samples, unless otherwise noted. XRD data for 37°C- and
freeze-dried CaP gels were given in the comparative chart of Figure 5.1a. Both
traces were characteristic of poorly-crystallized CaP powders,24,46–52 although
drying at 37°C seemed to cause a slight increase in the overall crystallinity with
respect to freeze drying. In freeze drying, the water initially present was gradually
sublimed, whereas in 37°C drying that water present at the end of the washing
step helped the crystallization to proceed at a low rate. Freeze-dried powders were
found to be fluffier with respect to those dried at 37°C, therefore, after the
preliminary experiments all of the powders obtained by aqueous synthesis
procedure were freeze-dried. Surface area measurements also confirmed this
observation, and the BET surface area of freeze-dried powders was 128 ± 5,
whereas that of the powders dried at 37°C for 72 h was 62 ± 3 m2/g.
Adult human bones yield XRD data very similar to those given in Figure
5.1a.69,70 If the syntheses were to be carried out under refrigeration, e.g., at around
4°C, the XRD charts obtained would consist of, more or less, X-ray amorphous
traces.68 The hydrated nature of CaP gel samples dried at 37°C were also
confirmed by the wide water bands displayed in their FTIR spectra given in
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Figure 5.1b. On the other hand, in the FTIR spectra of freeze-dried samples, the
intensities of those water bands have been significantly reduced (Fig. 5.1b).
Therefore, drying at 37°C did not completely eliminate the water present in those
precipitated precursor gels. The symmetric and antisymmetric stretching of the
PO4-3 group were observed at 1097, 1043, 964, 604, and 565 cm-1. Bands of CO32ions were observed at 1470–1420 and 875 cm-1. The very weak IR band at around
919 cm-1 and again the weak shoulder at around 1297–1310 cm-1 were attributed
to the smaller presence of HPO42- ions.71 HPO42- ions do also have a band at 874
cm-1, which partially overlaps with that of CO32- ions rendering the distinction
between HPO42- and CO32- ions more difficult. In contrast to our findings, Wu et
al.45 previously noted that unique HPO42- group present in the human bone
mineral was not seen in synthetic CaP samples produced under conditions similar
to those of this study. The synthesis procedure adopted and used in this study was,
therefore, able to produce a hydrated and carbonated CaP gel precursors, which
contained a trace amount of protonated orthophosphate ions similar to the human
fetal bones (Fig. 5.1b). The ICP-AES and C analyses results are given in Table
5.1. Analyses were performed in triplicate on all the samples. Freeze-dried CaP
gel precursors gave the following medians: Ca: 21.27 ± 0.02%; P: 13.27 ± 0.01%
and Na: 9.10 ± 0.01 wt %, which corresponded to a molar Ca/P ratio of 1.239
(Table 5.1), and a molar (Na+Ca)/P ratio of 2.163 in these powders. It is not so
surprising that even if one started with a nominal precipitation solution Ca/P
molar ratio of around 0.5, the precipitates formed at or near the physiological pH
would still be Ca-deficient apatitic CaP. C analyses proved that the precursor
powders were carbonated, and the carbonate content decreased with an increase in
the calcinations temperature, while the Ca/P molar ratio and the Na content
remained almost the same.
When the pH values of the same precipitation solutions were fixed at
around 4.2, then the formed powders only consisted of the brushite phase (DCPD,
CaHPO4.2H2O), whose XRD and FTIR data are not shown here to save space.
The size and shape of those brushite crystals were also perfectly the same as
mentioned elsewhere.72 The SEM morphology of the freeze-dried powders was
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Fig. 5.1 (a) XRD traces and (b) FTIR traces of 37°C-heated and freeze-dried CaP
gel precursors
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Fig. 5.1 (c) & (d) SEM micrographs of freeze-dried CaP gel precursors at two
different magnifications

Table 5.1

Freeze-dried
300°C
400°C
500°C
600°C
1000°C

Results of ICP-AES and C Analyses (in wt %, average of 3 runs)
Ca
21.27
28.93
28.49
28.36
29.17
28.64

P
13.27
17.99
18.06
17.88
18.30
18.04

Sample
Ca/P (molar)
1.239
1.243
1.219
1.226
1.232
1.227
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Na
9.10
8.98
9.02
9.35
9.16
9.09

C
0.82
0.58
0.39
0.32
0.21
0.01

CO3
4.10
2.90
1.95
1.60
1.05
0.05

shown, at two different magnifications, in Figures 5.1c and d. The bright-field
TEM photomicrographs given in Figures 5.2a and b depicted the nanostructure of
the same powders. It should be noted that the selected-area electron diffraction
inset of Figure 5.2b proved the nanocrystalline nature of those powders.
TG/DTA/DSC analyses of the freeze-dried CaP precursors (Fig. 5.2c) indicated
that upon heating to 155–160°C the samples first lost around 7.5% of their initial
weight. This corresponded to the adsorbed water. Therefore, the water content of
the precursor powders was deduced to be around 7 to 7.5%. With continued
heating to 415°C, another gradual weight loss of about 2.5% was observed, and
this was probably due to the volatilization of the remnants of nitrate ions.
Characteristic IR bands for nitrate ions were to be found at 1440–1300 and 1070–
1030 cm-1,73 but in the IR spectra of Figure 5.1b it was quite difficult to identify
those nitrate bands because of severe overlapping with the phosphate and
carbonate bands over the same range. However, the weak bands at around 2200–
2030 cm-1 in Figure 5.1b can be ascribed to the nitrates.74 Further heating at above
415°C, up to 650°C, displayed the removal of carbonate ions that was
accompanied with a weight decrease of around 5 wt %, bringing up the total
weight loss to 15%. The temperature when one reached constant weight was
640°C (Fig. 5.2c).
β-Rhenanite, i.e., β-NaCaPO4, phase in these gel precursors started to
crystallize upon low-temperature calcination of the samples over the temperature
range of 300–600°C. Especially, the DSC spectrum given in Figure 5.2c showed
that there were two exothermic events taking place over the temperature range of
440–570°C. The starting points of these exothermic events were indicated with
arrows in Figure 5.2c. It should be noted that DSC is a dynamic process taking
place at a heating rate of 5°C/min, and under isothermal heatings the starting
points of those exothermic events would be slightly lower than those indicated by
the TG/DTA/DSC spectra. XRD spectra of Figure 5.3a showed the crystallization
of NaCaPO4 in a matrix of apatitic calcium phosphate. β-NaCaPO4 (sometimes it
may also be written as CaNaPO4) has an orthorhombic (space group Pnam62) unit
cell with the lattice parameters of a = 6.797, b = 9.165, and c =
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Fig. 5.2 (a) & (b) TEM micrographs of freeze-dried CaP gel precursors and (c)
shows TG/DTA/DSC spectra of freeze-dried CaP gel precursors - (a)
TG, (b) DSC, and (c) DTA spectra.
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5.406 Å.75 This phase (which will transform into α-NaCaPO4 at 650°C) is also
isostructural with β-K2SO4. The most straightforward way of synthesizing phasepure NaCaPO4 powders can be the solid state reactive firing of the powder
mixtures (in a 1:2:2 molar ratio) of Na2CO3, CaCO3, and (NH4)2HPO4 at 900–
950°C.75 However, such a synthesis route (which involves the formation of liquid
phases upon melting of first (NH4)2HPO4 and then Na2CO3) will not be able to
yield nanosize, therefore, high surface area and high surface reactivity powders.76
The peaks denoted by * (and their respective hkl reflections) were those of βNaCaPO4, and the 2θ positions of such peaks were in close agreement with those
given in ICDD PDF 29–1193. Upon heating at 600°C, CaP gel precursors of this
study crystallized about 40 ± 3% β-NaCaPO4. This value was calculated from the
data of Figure 5.3a by using the relative intensity ratio of the most intense peak of
hydroxyapatite (at 31.78° 2θ) to that of NaCaPO4 (at 32.59° 2θ). The samples
heated at 600°C for 6 h can therefore be named as 40% NaCaPO4–60% HA
biphasic biomaterials.
FTIR traces of the same calcined samples were depicted in Figure 5.3b.
CaP precursors calcined even at the low temperature of 300°C were able to
exhibit the characteristic OH- stretching vibration at 3572 cm-1, and this band
became more pronounced with the increase in calcination temperature at or above
500°C. The OH- bending vibration was also recorded at 634 cm-1.77 These bands
proved that the freeze-dried apatitic calcium phosphate phase (which lacked the
OH vibrations) present in the gel precursors completely converted into
hydroxyapatite upon calcination. Precipitated apatitic calcium phosphate
precursors need the humidity in the calcination atmosphere to transform into Ca–
hydroxyapatite upon heating.78–82 The relative humidity in our laboratories was at
around 65–70% during those calcination runs. Characteristic FTIR spectrum of
pure β-NaCaPO4 was previously given by Driessens et al.55 The orthophosphate
stretching bands for the 500°C-calcined samples were observed at 603 (v4), 962
(v1), 1020, and 1089 (v3) cm-1, which were contributed both by crystalline βrhenanite and apatitic calcium phosphate.77 The absence of the P─O─P

98

Fig. 5.3 (a) XRD spectra of CaP gel precursors heated in air from 300°C to
600°C (* and the respective hkl indices denote the reflections of βNaCaPO4, all the other peaks belong to HA); (b) FTIR traces of CaP gel
precursors heated in air for 6 h from 300°C to 600°C
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vibrational mode of pyrophosphates at 740 cm-1 (Fig. 5.3b) proved that the
calcined samples did not contain any traces of Ca2P2O7.77 If the amount of HPO42ions in the precursor powders were significant, then their conversion into
pyrophosphate would have been inevitable through the reaction 2HPO42- →
3P2O74- + H2O, which takes place at 600°C.31 Moreover, Loong et al.83
definitively demonstrated the lack or significant deficiency of OH- ions occupying
crystallographic sites in the Ca-deficient, non-stoichiometric apatitic crystals of
rat and bovine bones by using inelastic neutron-scattering spectroscopy.
It is known that an IR band at 1020 cm-1 can be attributed to the v3
vibration of PO43- in non-stoichiometric or Ca-deficient and/or carbonated apatitic
calcium phosphates; however, a band recorded at 1030 cm-1 is pinpointing to the
v3 vibration of PO43- in stoichiometric hydroxyapatite.84 Therefore, the relative
ratios of 1020/1030 bands in the FTIR spectra could provide a measure of mineral
crystallinity and maturity in bone minerals or apatitic-looking calcium
phosphates.77,85 While the samples calcined at 300°C or 500°C were displaying
that orthophosphate v3 vibration at 1020 cm-1, the same vibration was found to
shift to 1026 cm-1 in the 600°C-calcined sample (Fig. 5.3b). This can be ascribed
to the transition from non-stoichiometric to stoichiometric apatite together with
the crystallization of β-NaCaPO4 phase. On the other hand, it is interesting to note
here that for the gel precursor samples dried at 37°C the same v3 vibration was
recorded at 1027 cm-1, whereas the freeze-dried samples had it at 1020 cm-1, as
shown in the IR traces of Figure 5.1b. This means that drying those gel precursors
at 37°C for 72 h may have a positive effect on the progress of crystallization or
so-called “maturation.”
Variations in the grain size and morphology of the rhenanitehydroxyapatite biphasic powders, as a function of increasing calcination
temperature, were monitored by the SEM micrographs given in Figure 5.4. The
cracked-like grain/particle surfaces seen especially in the high magnification
micrographs of Figure 5.4 are the artifacts created by the Pt-coating layer. Grain
sizes directly measured from the SEM micrographs, as well as the respective
surface areas of these powders, is given in Table 5.2.
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Fig. 5.4 SEM morphology of freeze-dried CaP gel precursors heated: (a) & (b) at
300°C; (c) & (d) at 400°C; (e) & (f) at 500°C; and (g) & (h) at 600°C
(two different magnifications are reported)
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Table 5.2
Sample
Freeze-dried
300°C
400°C
500°C
600°C

Grain Sizes and Surface Areas of Powders
Grain Size (nm)
45 ± 10
60 ± 10
100 ± 10
150 ± 10
300 ± 70

Surface area (m2/g)
128 ± 5
79 ± 4
70 ± 5
53 ± 3
34 ± 3

Even after light calcination at temperatures from 300 to 600°C, these
materials retained their initially small grain sizes still in the nano- or submicronrange. These surface area data were quite comparable to those reported by
Somrani et al.51 in a study on the thermal evolution of poorly-crystalline apatitic
calcium phosphate powders produced by using Ca-nitrate tetrahydrate and
diammonium hydrogen phosphate as the starting water soluble reagents, in the
absence of any Na ions in their precipitation solutions. Apatitic calcium phosphate
samples of Somrani et al.51 decomposed into crystalline tricalcium phosphate
upon calcination. Freeze-dried samples of the current study consisted of (as
shown in the micrographs of Figs. 5.1 and 5.2) particles (or moieties) having a
needlelike morphology with average dimensions of 10 (thickness) and 70 (length)
nanometer. These are very well within the size range of bone apatite crystals,
which were documented by using electron microscopy for more than 5 decades
ago.27,86 Johansen and Parks87 reported that bone apatite crystallites were platelike
in shape with dimensions 400 x 200–350 x 25–50 Å. Upon calcination of the
samples of this study, those initially plate- or needle-like, longitudinal moeities
present in the freeze-dried powders (Figs. 5.1 and 5.2) tended to form more or less
equiaxed or globular grains (Fig. 5.4). Such a tendency of nanosize globule
formation upon heating can also be taken as a sign of those moieties (Fig. 5.2)
actually being comprised of very much smaller particles. Indeed, early studies by
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Molnar88,89 suggested that bone crystals are composed of chains of microcrystals
fused in an end-to-end relationship. An X-ray diffraction study by Posner et al.90
reported that the largest dimension of the bone apatite crystals was about 100 Å,
and those apatitic crystallites should be regarded as a mosaic of microcrystals
rather than as a continuously uniform, single crystal.31 The sodium-doped calcium
phosphate gel precursors of this study [enthused by the work of Refs. 24, 48, 68]
consisted of poorly-crystallized apatitic microcrystals very similar in dimensions
and appearance to those of bone mineral.
Nakahira et al.,91 in a study of testing the applied magnetic field on the
bioactivity of hydroxyapatite, reported the formation of NaCaPO4 as a second
phase in 10% NaHCO3- mixed hydroxyapatite bioceramic samples upon sintering
those at 1000°C. These authors blended the hydroxyapatite and NaHCO3 (at 10%
level) powders by using a conventional ball-mill, followed by compaction, cold
isostatic pressing, and sintering. Nakahira et al.91 also tested the bioactivity of
those

1000°C-sintered

samples

by

soaking

them,

at

37°C,

in

SBF

(simulated/synthetic body fluid92,93) solutions from 4 to 7 days. It is quite
interesting to note here that, under the identical SBF soaking conditions,
according to Nakahira et al.,91 while the pure hydroxyapatite samples (with no
magnetic field application) were not showing any bonelike CaP deposits on their
surfaces, NaCaPO4-containing samples were covered with a high abundance of
such deposits. This was again attributed to the higher bioactivity of NaCaPO4
phase than that of pure hydroxyapatite.91,94 Although we did not include an SBFsoaking study in this manuscript, the strong evidence brought upon by the work of
Nakahira et al.91 was considered to be sufficient to ascertain the bioactivity (in
SBF solutions) of such NaCaPO4-containing hydroxyapatite bioceramics.
Moreover, the presence of Na ions that weaken the bond between Ca2+ and PO43in the crystal surface accounts for the high dissolution rate of β-NaCaPO4. If the
surface of a bioceramic sample inserted in an SBF solution exhibits such a
significant ionic level dissolution phenomenon, then the Ca2+ and HPO42- ions to
be abundant on these surfaces will further trigger the aggregation, and the
consequent surface segregation, of Posner’s clusters found in those solutions.95
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The NaCaPO4–HA biphasic powders of this study sintered well even after
heating them at the low temperature of 1000°C for 6 h in air as pressed pellets.
The SEM photomicrographs given in Figure 5.5a and 5b (insets showed a higher
magnification view) depicted the surface of the well-densified pellets heated at
1000°C for 6 hours after cooling at the rate of 5°C/min and 1°C/min, respectively.
It is interesting to note that even the chemically synthesized, submicron HA-TCP
biphasic powders do not show a densification rate (even after heating those at
1200°C) as high as the samples of this study.96 Cooling rate was found to have a
pronounced effect on the NaCaPO4–HA biphasic samples though. Samples cooled
at the rate of 5°C/min (Fig. 5.5a) showed a larger number of both inter- and intragranular cracks, when the cooling rate was decreased to 1°C/min (Fig. 5.5b) those
cracks were reduced. The mismatch between the coefficients of thermal
expansion of NaCaPO4 and HA phases might be responsible for the formation of
those cracks. Pellets sintered at 1000°C still had the same biphasic nature (i.e.,
60% HA - 40% NaCaPO4) and their XRD spectra were in strong resemblance to
those given in Figure 5.3a for the 600°C-calcined powder sample. Sintering the
biphasic samples at 1000°C for 6 hours did not destroy the original phase
constitution. However, as expected, the FTIR spectra of the 1000°C-sintered
pellets did not exhibit the carbonate bands. Carbonate ions in apatitic calcium
phosphate structures cannot easily persist at temperatures greater than 700–
750°C. Nevertheless, a more detailed study of the sintering behavior of these
biphasic powders, with the aim of forming dense, carbonate ion-free ceramics of
low surface area, over the temperature range of >1000–1300°C was out of the
scope of this study.
β-NaCaPO4 phase was recently reported by El-Ghannam61 to form upon
the calcination (180–800°C) of a new class of SiO2–CaHPO4.2H2O physicallymixed powder blends initially wetted by rather concentrated NaOH solutions. In
vivo studies performed by El-Ghannam61 found that these materials were superior
to Bioglass® in terms of protein absorption, enhancement of bone generation, and
overall resorption. Gong et al.60 reported that crystalline β-rhenanite in contact
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Fig. 5.5 600°C-calcined biphasic powders sintered at 1000°C for 6 h and cooled
at the rate of (a) 5°C/min and (b) 1°C/min
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with SBF solutions may act as a nucleation precursor for the formation of apatitic
calcium phosphates with respect to the following reaction:
3NaCaPO4 + 2Ca2+ + H2O → 3Ca5(PO4)3OH + 3Na+ + H+ (1)
Kangasniemi et al.97 prepared _-rhenanite powders by sintering
stoichiometric mixtures of CaHPO4 and Na2CO3 at 1300°C, followed by sieving
the ground sintered chunks to a size below 45 µm, and used those later as
crystalline additives (from 20 to 30 wt %) in their experimental bioactive glass
compositions. The same authors were then reported in a separate study98 the
dissolution behavior of crystalline β-rhenanite- or crystalline HA-containing
bioactive glasses soaked in SBF from 5 h to 6 days. Kangasniemi et al.98
concluded that the β-rhenanite-containing composites had a very positive effect
on the rate of apatitic CaP layer formation on the surfaces of samples soaked in
SBF.
The earlier but quite comprehensive work of Ramselaar et al.54–56 should
be taken as a good reference for the strong potential of β-rhenanite in developing
resorbable or osteoinductive calcium phosphate bioceramics. The in vivo canine
studies performed by Ramselaar et al.56 demonstrated that statistically more bone
deposition occurred on β-rhenanite particles than on hydroxyapatite particles.
This study showed that by simple calcination of a poorlycrystallized, Nacontaining calcium phosphate gel precursor synthesized at the physiological pH it
will be possible to form biphasic biomaterials consisting of a high solubility βNaCaPO4 and less soluble nanosize hydroxyapatite. Since the starting material is
a gel precursor, it can be easily shaped (for instance, by extrusion, injection
molding or solid freeform fabrication techniques) into any desired threedimensional form before the full crystallization of the phases to take place during
the final calcination step. The initial viscosity of such gels can be readily adjusted
prior to the form fabrication. We have also observed that these gels can even be
stored in ordinary zip-lock, air-tight nylon bags for more than a year (under
refrigeration at 4°C), without resulting in any detectable changes in their XRD
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and FTIR patterns. Moreover, leachable porogen phases or particulates (such as,
NaCl, ammonium carbonate, ammonium acetate, ice crystals, etc.) may also be
incorporated into these gels for forming porous bodies at the end of the
fabrication processes. The only delicate step in the use of such preformed gels for
forming 3D shapes would be the careful drying in a relative humidity controlled
environment that should avoid the formation of drying cracks due to the rapid
removal of entrapped water.
The osteoinductive character reported99–101 for the biphasic β-TCP (40%)
and HA (60%) biomaterials may also be expected for the β-rhenanite-HA
materials of this study. Finally, to validate the above speculation and the clinical
usefulness of the β-rhenanite + HA biphasic biomaterials of this work in vivo
studies must be performed, which we plan to report in a follow-up study.
5.4

Conclusions
Sodium-doped calcium phosphate precursors were produced at room

temperature by using a robust aqueous synthesis procedure involving the use of
Na2HPO4, NaHCO3, and Ca(NO3)2.4H2O. The precursors formed at the
physiological pH of 7.4 were in the form of a gel. Upon freeze-drying, these
precursor gels were found to consist of poorly-crystallized, nanosize apatitic
calcium phosphates with a surface area in excess of 120 m2/g. Calcination of these
samples in a static air atmosphere over the temperature range of 400–600°C for 6
h led to the production of β-rhenanite and hydroxyapatite biphasic biomaterials.
Calcined powder samples had surface areas over the range 30 to 80 m2/g, and
consisted of nanosize grains.
5.5.
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CHAPTER 6
PREPARATION OF Zn-DOPED β-TRICALCIUM PHOSPHATE (βCa3(PO4)2) BIOCERAMICS
Abstract
Pure β-tricalcium phosphate (β-TCP) and Zn-doped (600, 2900, 4100, 7000, 9300
and

10100

ppm)

β-TCP

samples

were

prepared

by

using

a

wet

chemical/coprecipitation synthesis technique, followed by calcination at 1000°C
in air. Precursor powders of the coprecipitation process were Ca-deficient
nanoapatites (i.e., Ca/P molar ratio varying from 1.49 to 1.51) with needlelike but
agglomerated particles of 30 nm thickness. In vitro culture tests performed by
mouse osteoblast-like cells showed that the samples doped with 2900 to 4100
ppm Zn showed the highest cell viability (via Live/Dead counts), and with a
further increase in the Zn-content towards 1 wt% the number of dead cells in the
well plates started to increase. Alkaline phosphatase (ALP) activity peaked for the
β-TCP sample doped with 4100 pm Zn. The sample surface roughness, measured
by non-contact profilometry, was also found to have an effect on the Live/Dead
cell counts, and the highest cell viability encountered in this study corresponded
to the surface with the least roughness.

(This work is published in Mater Sci Eng C 27 (2007) 394–401)

6.1.

Introduction
The mineralized portion of human bones and teeth essentially consists of

nanosize and imperfect crystals of Ca-deficient, carbonated and alkali- and
alkaline earth-doped biological apatites.1 Bone apatites do not contain the βtricalcium phosphate (β-TCP: β-Ca3(PO4)2) phase. However, Mg-doped
whitlockite, which can form in aqueous environments and structurally related to
β-TCP, was found in human dental calculus2 and in carious lesions3,4. Human
bone depositing cells, namely the osteoblasts, are not programmed to synthesize
the β-TCP phase in their physiological habitat, pH and temperature. β-TCP is a
calcium phosphate ceramic of high solubility in comparison to Ca-hydroxyapatite
(HA; Ca10(PO4)6(OH)2). The solubility activity product (Ksp) of β-TCP is 2.51x1030 5, 6

,

whereas that of HA is 2.34x10-59 7. Owing to its significant solubility and

ability of taking part in bone remodeling/turnover processes, β-TCP has become a
bone substitute bioceramic in successful clinical use.8-10 Wiltfang et al.11 reported
the in vivo resorbability (more than 95%) of β-TCP bioceramics in a minipig-tibia
model observed over a period of 86 weeks.
The human nutritional need for zinc is small, but its role in growth and
well-being is enormous, starting even before birth.12 The entire body of a normal
human weighing 70 kg may contain 1.4 to 2.3 g of zinc, and the recommended
daily allowance of zinc is between 8 and 15 mg. Meats, seafood (especially
oysters) and liver are the richest sources of zinc in food; brewer’s yeast, milk, egg
yolks, popcorn, beans, cocoa, and wheat germ also supply some zinc.13 Zinc is
found in body in small amounts in almost all tissues, however, the bones, teeth,
and the pancreas contain slightly higher amounts than others. Human blood
plasma contains approximately 1.5x10-2 mM of zinc.14 Zinc is an essential trace
element in a variety of cellular processes including DNA synthesis, behavioral
responses, reproduction and virility, bone formation, bone growth and wound
healing.15 Zinc plays an important role in gene expression and in the regulation of
cellular growth and differentiation,16 since it participates as a co-factor of more
than 200 enzymes implied in the metabolism of nucleic acids, carbohydrates and
proteins. Approximately 85% of the body store of zinc is found in skeletal
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muscles (55%) and bones (30%).17 The necessity of this trace element for bone
growth was demonstrated by the observation that normal bone growth was
retarded in animals that are zinc-deficient,18 and the addition of zinc to these
deficient diets resulted in a stimulation of both bone growth and mineralization.19
Zinc is the only metal to be incorporated in all six enzyme classes of
metalloenzymes, with the examples of oxidoreductase, transferase, hydrolase,
lyase, isomerase, and ligase activity.20 Important bone enzymes, including
alkaline phosphatase (ALP) and carbonic anhydrase are zinc metalloenzymes, and
tartrate-resistant acid phosphatase (TRAP) is strongly inhibited by zinc

21, 22

. In

brief, zinc deficiency has been associated with skeletal growth retardation,
reduced ALP activity18, reduced premenopausal bone mass23 and postmenopausal
osteoporosis24. Clinical trials have also shown that zinc supplementation inhibits
postmenopausal bone loss

25

. Zinc has been implicated in bone formation,

mineralization,26 and the stimulation of ALP activity in calvarial organ cultures,18,
27

osteoblast-like cell cultures,28-30 as well as the stimulation of the bone DNA

synthesis via the activation of bone DNA polymerase31. Zinc deficiency, on the
other hand, were recently shown to cause about 300% increase in programmed
cell death (or apoptosis) in mice in a variety of kinds of cells32, and insufficient
zinc initiated apoptosis in hepatocytes, glioma, kidney, monocytes, fibroblasts,
and testicular cells.
To the best of our knowledge, a thorough investigation on the synthesis of
Zn-doped HA and/or TCP bioceramics has a rather short history. Fuierer et al.33
and Bigi et al.34 performed the pioneering studies in this field, which reported the
inhibiting effect of zinc on HA crystal growth in aqueous systems. A later report
by Bigi et al.35 attempted to synthesize Zn-doped β-TCP bioceramics at Zn
dopant levels from 2.5 to 20 mole%, with increments of 2.5 mole% over this
range. Bigi et al.35 first prepared single-phase β-TCP ceramics by calcining a
stoichiometric powder mixture of CaHPO4⋅2H2O and CaCO3 at 1000°C for 15 h.
To produce the Zn-doped β-TCP bioceramics, Bigi et al.35 mixed the phase-pure
β-TCP powders with those of α-Zn3(PO4)2 and calcined the resultant mixtures at
1000°C for 15 h. Bigi et al.35 concluded that the small Zn ion (0.074 nm) readily
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replaced the larger Ca ion (0.099 nm) in the β-TCP structure (rhombohedral,
space group R3c), causing a steady and monotonic decrease in the a-axis of the
unit cell from 10.44 to 10.325 Å, while causing a slight decrease in the c-axis
length from 37.41 to 37.25 Å, with isomorphic Zn substitution from 2.5 to 20
mol% over the Ca-sites. LeGeros36, 37 has been the first to report the formation of
TCP phase (together with needle-like apatite crystals) in aqueous solutions
containing zinc. The last five years have seen a number of publications38-51
coming from the laboratory of Dr. Atsuo Ito, all concerning with the synthesis
and/or in vitro-in vivo testing of Zn-containing calcium phosphate ceramics. In
some studies of the Ito group, the ZnTCP samples (to be later blended with HA
powders) were prepared by the Ca(OH)2-H3PO4 neutralization route with the
addition of zinc nitrate into those solutions to obtain 10 to 30 mol% Zn doping,39
while in some studies by Layrolle et al.52 a sol-gel route, which used Ca(OEt)2
(obtained from the reaction of Ca metal shots and ethyl alcohol), H3PO4 and Znacetate, was employed to synthesize the samples. The Ito group synthesized
numerous calcium phosphate samples by doping Zn starting from 600 ppm level
up to 10-20 mol%.48 However, most of the studies of this group were focused
more on the in vivo and in vitro testing of ZnTCP-HA biphasic samples.
Therefore, the reports originating from the Ito group which focused only on the
testing of Zn-doped β-TCP (i.e., without any HA) 41, 45, 50, 51 are in direct relevance
with the present study. However, in these studies the following points can be
underlined: (i) their powder samples were produced by using the Ca(OH)2-H3PO4Zn-nitrate synthesis route,41, 45, 50, 51 (ii) when the authors were adding 12 mol%
Zn, their samples were reported to contain the phase of CaZn2(PO4)2,51 (iii) the
authors first synthesized 10 mol% ZnTCP powders and then mixed those in a
mortar with pure β-TCP powders to obtain 0.28, 2.56, 5.0, 7.47, and 10.5% Zncontaining ZnTCP samples after calcination at 1000°C,45 (iv) when the authors
were preparing the so-called 12 wt% Zn-containing ZnTCP samples, they
reported to have the secondary phases of Ca2.7Zn0.3(PO4)2 and CaZn2(PO4)2,

41, 50

(v) the authors never cited the important work of Bigi et al.35 and compared their
findings with those reported before, (vi) the authors did not study the low end of
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the Zn-doping range. The goals of the present study can be briefly stated as
follows; (i) to develop an aqueous co-precipitation process (incorporating a
calcination step; at 1000°C) for synthesizing Zn-β-TCP samples with Zn levels
ranging from 600 ppm to about 1.0 wt% to eliminate the need for physical mixing
of more than one powders to produce Zn-doped calcium phosphate bioceramics,
(ii) to characterize the samples by using XRD, FTIR, TGA, ICP-AES, density and
surface profilometry measurements, (iii) to test the cytotoxicity and ALP (alkaline
phosphatase) activity of the Zn-β-TCP samples (600, 2900, 4100, 7000, 9300 and
10100 ppm Zn) by using rat osteoblast-like cells.
6.2.

Experimental Procedure

6.2.1

Sample preparation. Ca(NO3)2⋅4H2O (>99.5%, Fisher), NH4H2PO4

(>99.5%) and Zn(NO3)2⋅6H2O (>99.9%) were the starting chemicals used in
powder synthesis. α-Zn3(PO4)2 powder (TZP; 99.995%, #13013) was provided by
Alfa-Aesar Inc. Briefly, NH4H2PO4 was dissolved in deionized water in a glass
beaker, and in a separate beaker Ca(NO3)2⋅4H2O and Zn(NO3)2⋅6H2O were
dissolved in proper amounts. Ca-Zn-nitrate mixed solution was then added at once
into the phosphate solution, the slight turbidity instantly observed was eliminated
by adding few drops of concentrated HNO3 (69 vol%, Fisher) which also brought
the solution pH down to 3±0.1 from around 4, and therefore, a clear solution was
obtained. This solution was stirred (200 rpm) at 37°C for 2 h to ensure a
homogeneous mixture, followed by rapidly adding about 50 mL of a concentrated
NH4OH (29% NH3, Merck) solution to obtain precipitation and a stable pH value
of around 9.2 ±0.2 again at 37°C. The opaque solution was stirred for 1 h. Formed
precipitates were filtered (paper No. 42) via a Buechner funnel, washed with 4 L
of water, and then dried at 90°C for 12 hours in air in glass dishes. Dried powders,
which were free of hard agglomerates, were only lightly ground in an agate
mortar by a pestle. Precursor powders were uniaxially pressed (3580 kg/cm2) into
1.5 mm-thick, 1.27 cm-diameter pellets in steel molds and then calcined in air at
1000°C for 6 h in clean Al2O3 boats or crucibles (heating/cooling rate: 3°C/min).
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Table 6.1

Powder synthesis procedure

ppm Zn in β-TCP, measured by ICP-AES in powder samples calcined at 1000°C
for 6 h
b
ICP-AES analyses of powder samples calcined at 1000°C for 6 h
a

TZP powders were also pressed into pellets and later calcined in the way as
described above. The details of powder syntheses were given in Table 6.1, in
which the samples of interest were named according to their experimentallydetermined (by ICP-AES) ppm Zn values after calcination.
6.2.2

Characterization. Chemical analyses of powder (both precursor and

calcined) samples were performed by ICP-AES (Model 61E, Thermo Electron,
Madison, WI). During the ICP-AES analyses, 50 mg portions of powder samples
were dissolved in 5 mL of concentrated HNO3 solution. Surface roughness of the
calcined Zn-β-TCP pellets were measured, prior to cell culture tests, by a noncontacting surface profilometer (NT-2000, Wyko, Tucson, AZ) at the
magnification of 25 X and over a 164 x 215 µm field of view. In profilometry, Rt
was the maximum height minus the minimum height in the field of view, whereas
Rz was the average of 5 highest peaks minus the average of 5 lowest valleys. Bulk
densities of the calcined pellets (repeated 5X) were measured by using a
pycnometer (AccuPyc 1330, Micromeritics, Norcross, GA) with He gas.
For the phase analyses of powder samples an X-ray diffractometer (XRD;
XDS 2000, Scintag Corp., Sunnyvale, CA) was used (Cu Kα radiation at 40 kV
and 30 mA, with a step size of 0.03° and preset time of 1 s at each step). Samples
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were also analyzed by FTIR (Nicolet 550, Thermo-Nicolet, Woburn, MA).
Scanning electron microscopy (FE-SEM; S-4700, Hitachi, Tokyo) was used in the
secondary electron mode with an acceleration voltage of 5 kV to image the
samples.
6.2.3

In vitro cell culture tests. Statistical sample size (i.e., n) was 16 in the

entirety of the cell culture tests.7F2 rat osteoblast-like cells (CRL-12557,
American Type Culture Collection, Rockville, MD) were grown on 75 cm2
culture flasks at 37ºC and 50% CO2 in α-MEM with 2 mM 1-glutamine and 1
mM sodim pyruvate without ribonucleosides and deoxyribonucleosides,
augmented by 10% FBS. The culture medium was changed every other day until
the cells reached a confluence of 90-95%, as determined visually with an inverted
microscope. The cells then were passaged using trypsin (2.5 g/L)/ EDTA (25mM)
solution (Sigma-Aldrich Corp., St. Louis, MO, USA). The obtained cells were
then seeded at a concentration of 3500 cell/well on 0.14 cm3 samples for various
assays. Cell viability and alkaline phosphatase activity measurements were
performed after 72 hours. The cell viability assessment was performed using
Live/Dead® Viability/Cytotoxicity Kit (L-3224, Molecular Probes, Eugene, OR).
A working solution is prepared by mixing 5µl aliquot of Component A (4 mM
calcein AM solution in DMSO) to 10 ml of 4 mM EthD-1 solution (20 µl of the
Component B to 10 ml of DPBS). 100 µl of this working solution was added to
the cell-containing samples along with 100 µl of cell-containing media. Samples
were incubated at room temperature for 30-45 minutes. After the prescribed time
period, the fluorescence values were recorded at 494/517 nm for live cells and
528/617 nm for dead cells by using a standard curve obtained by seeding different
number of cells in different wells. The alkaline phosphatase (ALP) activity was
determined using the ALP concentration and the cell extracted protein
concentration. The ALP concentration was calculated using Enzymatic Assay of
Phosphatase Alkaline Kit (EC 3.1.3.1, Sigma-Aldrich Corp., St. Louis, MO,
USA). A working reagent was prepared by first mixing 2.7 ml of Reagent A (1.0
M Diethanolamine Buffer with 0.50 mM Magnesium Chloride) with 0.30 ml of
Reagent B (150 mM p-Nitrophenyl Phosphate Solution (pNPP)) and then mixing
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the mixture with 0.10 ml of cell-containing media. 100 µl of this solution was
added to each well and thoroughly mixed and incubated at 37ºC for 30 minutes.
Following incubation, the absorbance was recorded at 405 nm with the
spectrophotometer at room temperature. The standard curve was obtained by
plotting the absorbance measured at 405 nm for certain concentration against the
concentration in µg/ml. ALP concentration of each sample was then determined
using this standard curve and is expressend as µg-pNP/ml. The cell extracted
protein concentration was determined in a two-step procedure, first the protein
was extracted using M-PER™ Mammalian Protein Extraction reagent and then
this extracted protein was measured using BCA™ Protein Assay Kit. The cell
samples were lysed by adding 200 µl of M-PER™ Reagent to each well plate and
then shaking for 5 minutes. Lysate was collected and transferred to
microcentrifuge tubes, followed by centrifuging at 4000g for 10 minutes to pellet
the cell debris. Supernatant was transferred to clean tubes for analyzing the
protein concentration. To measure the protein amount, a working reagent (WR)
was prepared by mixing 50 parts of BCA™ Reagent A with 1 part of BCA™
Reagent B (50:1, Reagent A:B). 200 µl of the above mentioned WR was added to
each well and thoroughly mixed. Following mixing, the well plate was covered
and incubated at 37ºC for 30 minutes. The absorbance at 562 nm was measured
with the spectrophotometer at room temperature. A standard curve was prepared
by plotting the average blank-corrected 562 nm measurement for each BSA
standard versus its concentration in µg/ml. Cell extracted protein concentration
was then determined by using this standard curve and is expressed as µg/ml. The
ALP activity was then calculated as follows; ALP Activity = [(µg pNP)/139] /
µg(cell extracted protein) =

µmoles pNPP/ µg cell protein. Osteoblast

attachment/proliferation on the pellets was studied using SEM. Cells were first
fixed by using 3.5% glutaraldehyde, and then dehydrated through sequential
washings in 50%, 70%, 95% ethanol solutions and 2 times in 100% ethanol.
Samples were then critical point-dried, prior to sputter-coating with a thin layer of
Pt.
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6.3.

Results and Discussion
The pure and Zn-doped precursor powders of this study gave the same

XRD pattern as shown in Figure 6.1a, which belonged to that of Ca-deficient
apatitic calcium phosphate (CDHA: Ca9(HPO4)(PO4)5OH). Yubao et al.53
previously called this phase as apatite-TCP and gave a full account of its crystal
structure. Rietveld refinement of the structure of CDHA was performed by
Ivanova et al.54 and Tas et al.55. Gibson et al.,56 on the other hand, studied the
thermal transformation of CDHA into β-TCP. FTIR spectra of the precursor
powders were given in Figure 6.1b, while the ICP-measured Zn levels (in ppm)
were indicated on the diagram. The vibrations indicated in Figure 6.1b with
arrows denoted the OH vibrations, whereas the rest indicated the characteristic
PO43- and CO32- vibrations.56
It should hereby be noted that there was a difference between the ppm Zn
levels achieved in the powders before and after calcination (see Table 6.1). This
was believed to be due to the difference(s) in surface adsorbed or in hydroxideform Zn (i.e., in precursor powders) and the structure-assimilated Zn ions (i.e.,
after heating). Calcination, and therefore, the solid-state diffusion apparently had
a certain effect on the stabilization of the final Zn content of the samples.
According to the ICP-AES results of the precursors and the calcined samples,
vaporization of Zn was not observed during calcination. TGA traces of the
precursors (Fig. 6.1c) showed, from RT to around 500°C, an initial weight loss
between 4 to 9%, which corresponded to the loss of surface adsorbed water and
probably some residual ammonium and nitrate ions.54 The unique shoulder
observed at around 720°C in Figure 6.1c represented the volatilization of
carbonate ions. Carbonated nature of these precursor powders were also detected
by their FTIR spectra of Figure 6.1b. It was difficult to find a direct correlation
between the TGA weight loss behavior and the Zn-dopant level. The highmagnification SEM micrographs given in Figure 6.1d were recorded directly on
the surface of a green pellet prepared from 8700 ppm Zn-containing TCP
precursors, and the same morphology was also observed on 600 ppm Zncontaining precursors (data not shown). Micrographs of Figure 6.1d confirmed (as
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(a)

(b)

(c)

(d)

Fig. 6.1 Precursor samples (a) XRD spectra; (b) FTIR spectra; (c) TGA traces;
and (d) SEM micrographs (inset shows high magnification).
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did Fig. 6.1a) the nanocrystalline nature of these precursors, and the powders
consisted of acicular particles of about 100 nm-long and 30 nm-thick. TEM
studies are underway. Apparently, uniaxial pressing of those powders into a pellet
at 3580 kg/cm2 forced them to pack closely.
Calcination of the pure and Zn-doped precursor powders at 1000°C
resulted in the complete transformation of CDHA into β-TCP and Zn-doped βTCP. The Zn-content and Ca/P molar ratio of the calcined pellets were depicted in
Table 6.1. The XRD (Fig. 6.2a, Zn-content in ppm values were indicated on the
traces) and FTIR (Fig. 6.2b) spectra of the calcined samples confirmed the
formation of β-TCP. The small extraneous peaks in Figure 6.2a, labeled by
asterisks in the traces of 7000 and 9300 ppm Zn-containing samples,
corresponded to the very strong 211 reflection of the HA phase. In reproduction
runs for the samples these peaks were not observed, but we decided to report here
the original data. This probably showed an inherent limitation of our synthesis
procedure in producing 100% pure β-TCP.
Calcination of the precursors in an air atmosphere (at uncontrolled relative
humidity levels from one experiment to the other) may also be influential on this
point of HA formation. Surface profilometry data shown in Figure 6.2c indicated
to an interesting decrease in surface roughness at around 2900 and 4100 ppm Zncontent, with increasing or decreasing Zn-dopant level surface roughness
increased. The surface morphology of a pure β-TCP calcined pellet was given in
Figure 6.2d, grain sizes ranged from 350 nm to 2 µm. However, the grain size
distribution in 2900 and 4100 ppm Zn-β-TCP samples were quite different from
that of pure β-TCP, as shown in Figures 6.2e and f, respectively. The significant
increase in the average grain size of the 4100 ppm Zn-β-TCP sample should also
explain for the dip in the surface profilometry results given in Figure 6.2c. The
slight decrease in the average grain size in the 10100 ppm Zn-β-TCP sample (Fig.
6.2g) was interesting to note. These data showed that Zn was also an effective
dopant in altering the grain boundary area in this new class of β-TCP samples.
The progressive Zn doping caused a decrease in the bulk density of the pellets
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calcined at 1000°C, as shown in Table 6.2. The density data of Table 6.2
represented densification in excess of 95% of the theoretical density of β-TCP.
The 600 ppm Zn-β-TCP sample had the formula Ca2.997Zn0.003(PO4)2, whereas the
formula for the 10100 ppm sample was Ca2.952Zn0.048(PO4)2. The TZP pellet,
which was used as a control in the cell culture tests, showed the polymorphic
transformation from the α- (ICDD PDF 29-1390) to the β-form (ICDD PDF 301489) upon calcination at 1000°C (XRD and FTIR data not shown). This
polymorphic transformation in TZP was known to occur above 942°C.
The results of culture tests with mouse osteoblast-like cells were
summarized by the histograms given in Figures 6.3a (Live/Dead cytotoxicity) and
6.3b (ALP activity). Taking into consideration the rather significant length of the
error bar on the 2900 ppm Zn sample in Figure 6.3a and the highest ALP activity
observed for 4100 ppm Zn sample (Figure 6.3b), it can be stated that the
maximum proliferation of the osteoblast-like cells was recorded on the 4100 ppm
Zn-β-TCP sample of this study. It will also be interesting to couple this finding
with the fact that the minimum surface roughness (Figure 6.2c) and the maximum
bulk density (Table 6.2) values of this study were observed for the very same
4100 ppm Zn-β-TCP sample. β-TZP was found to be a perfectly cytotoxic
material (Figure 6.3a). It also became apparent that, in comparison to pure β-TCP,
the presence of Zn especially at the dopant levels of 2900, 4100 and 7000 ppm
significantly increased the osteoblastic activity (Figs. 6.3a and b).57 This point is
in very well agreement with the previous literature cited in Section 2. The
attachment and spreading of osteoblasts on various Zn-β-TCP pellets were
imaged by SEM and given in Figure 6.4. On pure β-TCP pellets, osteoblasts
spread like a thin, electron-translucent membrane so that the underlying grains
were still visible (Fig. 6.4a). The erosion of the grain boundaries (Fig. 6.4a)
during the cell culture tests may indicate that there might have been a highly
soluble amorphous CaP grain boundary phase which dissolved under the alkaline
phosphatase
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(a)

(b)

(c)
Fig. 6.2 Calcined samples (a) XRD spectra; (b) FTIR spectra; (c) Surface
profilometry.
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A

B

C

D

Fig. 6.2 SEM micrographs of calcined samples (d) 0 ppm (pure β-TCP), (e) 2900
ppm, (f) 4100 ppm, and (g) 10100 ppm Zn-βTCP.

Table 6.2 Bulk densities of Zn-doped β-TCP pellets
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Fig. 6.3 (a) Live/Dead (cytotoxicity) data and (b) ALP activity data for Zn- doped
β-TCP.

A

B

C

D

Fig. 6.4 SEM micrographs of osteoblast cells on (a) 0 ppm (pure β-TCP), (b)
2900 ppm, (c) 4100 ppm, and (d) 7000 ppm Zn-β-TCP pellet
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enzyme activity. The 2900 ppm Zn-containing sample surfaces (Fig. 6.4b)
showed a high degree of osteoblast coverage, and the inset in Figure 6.4b
displayed quite a significant degree of cell spreading. The cell nuclei became
visible even by the SEM images on 4100 ppm Zn-containing β-TCP samples (Fig.
6.4c). Typically, such imaging of cell nuclei could be achieved by using
fluorescent microscopy together with special histological staining practices. In
this case (i.e., 4100 ppm Zn), the cells were also proliferating into cytoskeletal
stress fibers beyond extending their filopodia. When the Zn-content was increased
to 7000 ppm (Fig. 6.4d), the cell attachment and spreading was still at quite high
levels. On the surfaces of β-TZP samples, it was not possible to find even a single
cell to image by the SEM, confirming the cytotoxicity results of Figure 6.3a.
Although the sample preparation routes of the two studies differed from
one another significantly, the findings of the present work enhanced those of Ito et
al.,45 especially at the ppm level Zn-doping into β-TCP. In vivo resorbability of
the samples of this study must be tested. The search for more reliable ways of Zndoping in calcium phosphates (HA, TCP or biphasic HA-TCP) and the in vitro
and in vivo characterization of the resultant samples seems to be an exciting field
of biomaterials research.58-62
6.4.

Conclusions

(1) Aqueous co-precipitation was used for synthesizing ppm-level Zn-doped βTCP precursor nanopowders. This method was suitable to produce 600, 2900,
4100, 7000, 9300 and 10100 ppm Zn-containing β-TCP samples after calcination
at 1000°C for 6 hours in air.
(2) Zinc was found to influence the grain growth characteristics and densification
of β-TCP samples. 4100 ppm Zn-doped β-TCP sample was observed to have the
highest bulk density within the range of dopant levels studied in this work.
(3) In vitro cell culture tests performed with mouse osteoblast-like cells showed
the significant effect of ppm level presence of Zn in β-TCP samples in enhancing
the osteoblastic activity, in direct comparison to pure β-TCP and β-TZP. The
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Live/Dead cytotoxicity counts and alkaline phosphatase activity data were
collected for all the samples.
(4) Live/Dead counts were peaked for the 2900 ppm Zn-β-TCP samples, whereas
the ALP activity was found to be the highest for the 4100 ppm Zn-containing βTCP samples.
6.5
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CHAPTER 7
ENHANCED BIOMIMETIC COATING OF COLLAGEN AND ITS IN
VITRO EXAMINATION
Abstract
Coating porous collagen membranes via a biomimetic method with a layer of
carbonated apatitic calcium phosphates was performed in this study. The
biomimetic process involves soaking the substrates in a simulated body fluid
(SBF) solution. The goal of this research was to enhance process kinetics of
biomimetic coating process by employing novel composition of SBF. For this
purpose, an improved version of SBF solution (tas-SBF, hereafter referred to as tSBF) was employed and is a TRIS-HCl buffered solution with a HCO3- ion
concentration of 27 mM. With the use of t-SBF, apatitic calcium phosphate
coatings homogeneously covered the collagen surface were performed over a 7
day period. This is a significant enhancement in the coating kinetics as opposed to
previous attempts. All samples were characterized by X-Ray Diffraction (XRD),
Fourier Transformed Infrared (FTIR) spectroscopy, and Field-Emission Scanning
Electron Microscopy (FE-SEM). Mouse osteoblasts (7F2) were used to compare
in vitro response of untreated collagen and SBF-coated collagen membranes via
the alkaline phosphatase activity, cell density and cell proliferation tests. These in
vitro results showed a more favorable response to the apatitic calcium phosphate
coating over the untreated collagen membrane.

(This work is submitted to J Eur Ceram Soc 2007)

7.1.

Introduction
A composite of collagen and apatite is of special interest because of their

compositional similarity with bone.1-4 In recent years, there is an increased effort
to produce apatite-collagen composite materials by innovative biomimetic
processing.4-11 Biomimetic coating process is employed to coat collagen
substrates to synthesize the apatite-collagen composites.12-20 This coating process
involves soaking the substrate in a supersaturated or metastable solution at human
body temperatures (37°C), which in turn forms several-micron-thick bioactive
layers of apatitic calcium phosphate nano-aggregates. It has been determined that
acellular physiological solutions such as synthetic or simulated body fluid (SBF)
solutions are able to induce such bioactive apatitic calcium phosphate layer on
metals, ceramics, and polymers (with proper surface treatments).21-23
SBF solutions maintain physiological conditions and are able to mimic the
ionic concentrations of human plasma. In 1990, Kukubo popularized one such
composition known as conventional simulated body fluid or “c-SBF”.21 However,
one disadvantage of c-SBF is that it contains lower carbonate ion concentration
than human plasma. In 1999, Tas et al.24,

25

increased the carbonate ion

concentration in a TRIS-HCl buffered SBF solution (tas-SBF, hereafter referred
to as t-SBF) to 27 mM (same as that of human plasma) while Bigi et al.26 did
similar experiments using a HEPES-NaOH buffered SBF solution. Kokubo et al.27
later increased the carbonate ion concentration of their c-SBF solutions from 4.2
to 27 mM by using HEPES-NaOH buffer and named it “revised-SBF” (r-SBF). A
detailed historical development of acellular physiological solutions since 1882 has
been summarized by the present authors elsewhere.28 The following sections
provide a brief review of biomimetic coating of collagen.
7.1.1

Biomimetic Coating of Collagen – A Brief Review
It is reported in the literature that the biomimetic coating kinetics of

collagen is very slow.14 Even after 4 weeks of soaking time, the collagen surface
was not fully covered by apatitic calcium phosphates.13 Several studies indicate
that an increase in the bioactivity of collagen can be achieved by modifying the
normal soaking procedures.12-20 These methods include either changing the
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chemistry of collagen or adding a compound to c-SBF solutions. Rhee et al.12
performed their experiments by soaking the collagen in SBF solutions with and
without citric acid. Although citric acid is known to be an inhibitor of calcium
phosphate formation,29 they determined that carbonated apatitic calcium
phosphates formed only on collagen in the SBF solution with an addition of citric
acid.12 The investigation of nucleation of apatite by the same authors indicated
that the coating is critically dependent on the carboxylate group of collagen.13
These results were later substantiated by Zhang et al.,14 who studied the growth of
apatitic calcium phosphates on the collagen membrane by phase-contrast
microscopy. They suggested that the charged functional groups of collagen
membranes play a key role in the growth of apatitic calcium phosphates.14 Several
theories were proposed to explain the formation of apatite layer on materials
soaking in an SBF solution. It was hypothesized that the apatite layer forms when
the material surface is negatively charged13, 30 and/or when silanol groups1,31 are
present on the surface. Chemical treatment by soaking the collagen discs in TEOS
at room temperature for 1h was performed by Andrade et al.15. This treatment
formed a silica coating on the collagen surface resulting in a negative charge upon
contact with the SBF solution, thus increasing the bioactivity.15 In 10 days, the
surface was not fully covered and the underlying collagen fibers were still
visible.15 Lickorish et al.16 deposited apatitic calcium phosphates on collagen by
soaking them in SBF in the presence of calcium silicate glass. They used two
different solutions, a nucleation solution and a growth solution. The nucleation
solution was formed by dissolving calcium silicate in SBF and a growth solution
was just SBF solution.16 The calcium silicate glass played an important role in
initiating apatite deposition on collagen substrates because when no glass was
present in the nucleating solution, apatite deposition failed to occur even after
soaking in the growth solution for 11 days. These findings support the hypothesis
of deposition via silanol mechanism. In this process, as reported in ref.,16 a
uniform thin coating of calcium phosphate forms on collagen after approximately
a total of 2 weeks of soaking time. The role of phosvitin on the nucleation of
apatitic calcium phosphates on collagen was investigated by Kobayashi et al.17 by
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forming a collagen-phosvitin composite. They found that the rate of calcium
phosphate nucleation is enhanced in the presence of phosvitin, and also
hypothesized that phosvitin controlled the orientation of the precipitated calcium
phosphates.17 Li et al.18 demonstrated the fabrication of three dimensional
collagen/wollastonite

composites

using

freeze-drying

methods.

These

collagen/wollastonite composites exhibited better deposition of apatitic calcium
phosphates after soaking in SBF for 7 days and the surface was uniformly covered
in 15 days, thus decreasing the coating time.18 Eglin et al.19 prepared collagen
hydrogel containing bioactive glass (CaO-P2O5-SiO2) and silica sol-gel particles
and studied their in vitro apatite-forming ability in SBF solution. The silicacollagen hydrogel composite precipitated calcium phosphate whereas silica
particles and collagen hydrogel alone did not, indicating a possible synergistic
effect between the collagen and silica on the apatite-forming ability.19 The
bioactivity of the nano-HA-collagen composite was also investigated by Lin et al.
20

. Their results show that the composite was coated with apatitic calcium

phosphates after 2 weeks of soaking in SBF.20 From these reported studies, it can
be concluded that modification of collagen or addition to SBF increases the
kinetics of the coating process and homogeneous coating of the collagen surface
in c-SBF takes at least 1-2 weeks. Even after modification, this process appears
lengthy as the dissolution of collagen in the liquid medium poses a relevant issue.
In view of these findings and the evolution of r-SBF27 with 27 mM HCO3concentration, attempts by Girija et al. were made to coat collagen in r-SBF.32 rSBF showed improvement in coating rate and was able to coat the collagen in just
2 weeks without any modification to either collagen or SBF.32 The reported SEM
micrographs show that the morphology of the apatitic calcium phosphates
deposited on the collagen substrate by r-SBF differed from those formed by cSBF. The same features are reported by Bigi et al.26 that showed the spherical
aggregates instead of nano-needles or nano-platelets morphology on gelatin films.
In order to further increase the coating rate, the presence of polyacrylic acid
(PAA) in collagen and in SBF was examined.33 The results showed that PAA not
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only affected the microstructure of apatitic calcium phosphates but their
mineralization as well.33
7.1.2

Effects of Various Coating Parameters on Coating Rate and
Morphology
As previously reported, the coating rate was slow when collagen was

soaked in c-SBF, even with modifications. The reason for the slow apatite
inducing ability of c-SBF is due to the low HCO3- concentration. A study by
Dorozhkina et al.34 emphasized the influence of HCO3- concentration in a TRISfree SBF solution on the morphology and thickness of calcium phosphate coatings
formed. They discovered an increase of the HCO3- concentration in c-SBF from
4.2 to 27 mM resulted in the formation of homogeneous and much thicker
carbonated hydroxyapatite layers.34 Similar results were obtained by Jalota et al.28
where they compared the coating abilities of TRIS-HCl buffered SBF solutions of
4.2 mM and 27 mM HCO3- concentration. They discovered that a t-SBF solution
with a HCO3- concentration of 27 mM was able to coat the titanium strips faster
than c-SBF solutions with a concentration of 4.2 mM HCO3-.28 Thus, in order to
increase the kinetics of the coating process in collagen, the present authors
suggest increasing carbonate ion concentration to 27 mM of the SBF.
A morphological difference was observed in the coatings produced by rSBF in comparison to those in c-SBF. This difference was also observed on
Ti6Al4V substrates in a recent study, where 27 mM HCO3- concentrated TRISHCl buffered (c- and t-) and HEPES-NaOH buffered (r-) SBF solutions were
compared.28 c-SBF and t-SBF solutions always produced round globules
consisting of intermingled nano-needles of calcium phosphates on Ti6Al4V strips
whereas r-SBF solutions produced nearly spherical aggregates.28 This
morphological difference between these SBF solutions is possibly due to
differences in the buffer used for preparation. Dorozhkina et al.34 emphasized that
HEPES was rather unstable, in comparison to TRIS, and that it easily loses some
of the initially present dissolved carbonates. Kokubo et al.,35 who developed the
HEPES-buffered r-SBF composition, also reported that r-SBF would release CO2
gas from the fluid. During longer storing periods, there was a decrease in HCO3concentration and an increase in pH value.35 Furthermore, they stated that r-SBF
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is unsuitable for long-term use in the biomimetic coating processes due to its
instability.35 Thus, the present authors suggest their preference for the TRISbuffer over the HEPES-buffer in making the SBF solution.
It was also reported that the rat osteoblast favorably responded to the
coating produced by TRIS-HCl buffered SBF solutions.28 This is due to the
resemblance of the thickness of the nanoplatelets or nanoneedles (20-30 nm)
produced by biomimetic coatings of TRIS-HCl buffered SBF solutions with the
bone mineral.36 Thus, 27 mM HCO3- concentrated TRIS-HCl buffered SBF
solutions is the most effective SBF solution in the coating of artificial materials.
7.1.3

Objectives
The current literature revealed that biomimetic coating of collagen was

attempted using c-SBF and r-SBF. No attempts were made to increase the coating
rate of collagen by increasing the HCO3- ion concentration (to 27 mM) in a TRISHCl buffered SBF solution (t-SBF). The performance of t-SBF was determined to
be superior than c- and r-SBF for Ti6Al4V substrates.28 In this present study, we
soaked porous collagen in t-SBF to evaluate the characteristics of the formed
apatitic calcium phosphate layer. The broad objective of the present work was to
establish a crack-free homogeneous coating with enhanced kinetics utilizing tSBF. A second objective was to compare the osteoblast response to the pristine
collagen surface with the apatite deposited collagen substrate.
7.2.

Experimental Procedure

7.2.1

Collagen Preparation. Porous membranes of collagen of approximately 1

mm thickness were obtained from Collagen Matrix Inc. (Franklin Lakes, NJ).
These membranes were first cut into 10 x 10 mm strips and then thoroughly
washed with deionized water. After washing, the strips were directly soaked in
1.5x t-SBF at 37±1ºC for a period of 3 and 7 days. The following paragraph
describes the procedure for preparing t-SBF.
7.2.2

t-SBF Preparation. The details of preparing the 1x t-SBF solution are

reported in Chapter 3, Section 3.2.2.
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7.2.3

Coating Process. The coating was performed in 100 mL-capacity glass

bottles, which contained 90 mL of SBF solution and the floating clean collagen
membrane. Sealed bottles were kept in an oven at 37±1°C for respective 3 and 7
day intervals. After every 48 hours, the used SBF solution was replenished. Both
sets of recovered samples for the respective 3 and 7 day periods were thoroughly
washed with deionized water, followed by a critical point drying process.
7.2.4

Characterization. All samples were characterized by powder x-ray

diffraction (XRD) (XDS 2000, Scintag, Sunnyvale, CA) using a CuKα radiation at
40 kV and 30 mA, with a step size of 0.03° and preset time of 1 second at each
step. Fourier-transform infrared spectroscopy (FTIR) (Nicolet 550, ThermoNicolet, Woburn, MA) measurements were performed using a diamond ATR
holder over the wave number range of 4000-525 cm-1 using 256 scan rate with a
resolution of 4 cm-1. The surface topography of untreated collagen membrane and
changes acquired upon soaking were analyzed using a field-emission scanning
electron microscopy (FESEM) (S-4700, Hitachi, Tokyo, Japan) at 5kV.
7.2.5

In Vitro Cell Culture Tests. 7F2 rat osteoblast cells (CRL-12557,

American Type Culture Collection, Rockville, MD) were grown on 75 cm2
culture flasks at 37ºC and 50% CO2 in α-MEM with 2 mM 1-glutamine and 1
mM sodim pyruvate without ribonucleosides and deoxyribonucleosides,
augmented by 10% FBS. The culture medium was changed every other day until
the cells reached a confluence of 90-95%, as determined visually with an inverted
microscope. The cells were then passaged using trypsin (2.5 g/L)/ EDTA (25mM)
solution (Sigma-Aldrich Corp., St. Louis, MO, USA). The cells were further
seeded at a concentration of 3500 cell/well on 0.14 cm3 samples for various
assays. Cell viability and alkaline phosphatase activity measurements were
performed after 72 hours. The cell viability assessment was performed using
Live/Dead® Viability/Cytotoxicity Kit (L-3224, Molecular Probes, Eugene, OR).
A working solution was prepared by mixing 5µl aliquot of Component A (4 mM
calcein AM solution in DMSO) to 10 ml of 4 mM EthD-1 solution (20 µl of the
Component B to 10 ml of DPBS). 100 µl of this solution was added to the cellcontaining samples along with 100 µl of cell-containing media. Samples were
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incubated at room temperature for 30-45 minutes. After the prescribed time
period, the fluorescence values were recorded at 494/517 nm for live cells and
528/617 nm for dead cells by using a standard curve obtained by seeding different
number of cells in different wells. The alkaline phosphatase (ALP) activity was
determined using the ALP concentration and the cell extracted protein
concentration. The ALP concentration was calculated using Enzymatic Assay of
Phosphatase Alkaline Kit (EC 3.1.3.1, Sigma-Aldrich Corp., St. Louis, MO,
USA). A working reagent was prepared by first mixing 2.7 ml of Reagent A (1.0
M Diethanolamine Buffer with 0.50 mM Magnesium Chloride) with 0.30 ml of
Reagent B (150 mM p-Nitrophenyl Phosphate Solution (pNPP) and then mixing
the solution with 0.10 ml of cell-containing media. 100 µl of this solution was
added to each well and thoroughly mixed and incubated at 37ºC for 30 minutes.
Following incubation, the absorbance was recorded at 405 nm with the
spectrophotometer at room temperature. The standard curve was obtained by
plotting the absorbance measured at 405 nm for certain concentration against the
concentration in µg/ml. ALP concentration of each sample was then determined
using this standard curve and is expressend as µg-pNP/ml. The cell extracted
protein concentration was determined in a two-step procedure. The protein was
first extracted using M-PER™ Mammalian Protein Extraction reagent and then
measured using BCA™ Protein Assay Kit. The cell samples were lysed by adding
200 µl of M-PER™ Reagent to each well plate and then shaken for 5 minutes.
Lysate was collected and transferred to microcentrifuge tubes, followed by
centrifuging at 4000g for 10 minutes to pellet the cell debris. Supernatant was
transferred to clean tubes for analyzing the protein concentration. To measure the
protein amount, a working reagent (WR) was prepared by mixing 50 parts of
BCA™ Reagent A with 1 part of BCA™ Reagent B (50:1, Reagent A:B). 200 µl
of the above mentioned WR was added to each well and thoroughly mixed.
Following mixing, the well plate was covered and incubated at 37ºC for 30
minutes. The absorbance at 562 nm was measured with the spectrophotometer at
room temperature. A standard curve was prepared by plotting the average blankcorrected 562 nm measurement for each BSA standard versus its concentration in
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µg/ml. Cell extracted protein concentration was then determined by using this
standard curve and expressed as µg/ml. The ALP activity was then calculated as
follows; ALP Activity = [(µg pNP)/139] / µg(cell extracted protein) = µmoles
pNPP/ µg cell protein. Osteoblast attachment/proliferation on the pellets was
studied using SEM. Cells were first fixed by using 3.5% glutaraldehyde, and then
dehydrated through sequential washings in 50%, 70%, 95% ethanol solutions,
followed by 2 times in 100% ethanol. Samples were subsequently critical pointdried, prior to sputter-coating with a thin layer of Pt.
7.3.

Results

7.3.1

XRD Analysis
The phase identification was performed by x-ray diffraction (XRD). The

broad peak due to collagen membrane was observed in the 2θ range of 12°-30° in
Figure 7.1a. After soaking in 1.5x t-SBF for 7 days, peaks of apatitic calcium
phosphates were observed at 25.9, 28.7, 32.02, and 39.75 respectively (Fig. 7.1b).
The broadening of the apatite peaks is due to the small crystallite size of apatite.
Figure 7.1c shows the XRD trace of a rat bone. The XRD pattern formed on
collagen after soaking in SBF matched exactly with that of the bone.
7.3.2

FTIR Analysis
We used FTIR spectroscopy in order to illustrate the formation mechanism

of bone mineral-like apatite and the chemical interaction of apatite with the
collagen membrane. The result shows the traces for untreated collagen (Fig. 7.2a),
collagen soaked in t-SBF for a period of 7 days (Fig. 7.2b) and a rat bone (Fig.
7.2c). The FTIR trace of untreated collagen (Fig. 7.2a) shows the typical bands of
N―H stretching at 3310 cm-1 for amide A, C―H stretching at 3080 cm-1 for
amide B, C═O stretching at 1631 cm-1 for amide I, N―H deformation at 1549
cm-1 for amide II and N―H deformation at 1238 cm-1 for amide II bands. After
soaking the collagen in SBF for 7 days (Fig. 7.2b), all the absorption bands of
collagen disappeared except at 1557 and 1633 cm-1. These two are the most
intense bands of collagen and their intensity significantly decreased after soaking
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Fig. 7.1 XRD traces of (a) untreated collagen; (b) collagen soaked in t-SBF for 7
days; and (c) rat bone.

Fig. 7.2 FTIR traces of (a) untreated collagen; (b) collagen soaked in t-SBF for 7
days; and (c) rat bone.
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in SBF for 7 days. This is considered an evidence of a chemical reaction between
calcium phosphate deposited with the collagen and formation of a thick coating
layer on collagen. Interestingly, the calcium phosphate formation did not affect
the characteristics of collagen. The calcium phosphate coating was confirmed to
be apatitic in nature due to the presence of PO43- bands at 1021, 608, and 561 cm1

. The crystallinity of this apatite is low because the spectrum is not so sharp as

that of well crystallized HA. The absorption bands present at 1420-1470 cm-1 and
870 cm-1 also revealed the presence of CO32-. Some minor peaks are also evident
at 961, 1122, and 1230 cm-1, which were due to the presence of HPO42- ion in the
coating. Therefore, FTIR results confirmed that the apatitic calcium phosphate
also contained CO32- and HPO42- ions. The absence of the stretching and the
vibrational modes of O-H group at 3571 and 639 cm-1 confirmed that these
coatings might not simply be named as hydroxyapatite.
In order to further analyze the coatings, we also collected the FTIR data
from rat bone (after cleaning and removing the bone marrow) which is depicted in
Figure 7.2c. The similarity of the coating with the bone mineral (rat bone) is
shown in Figure 7.2. Bone mineral is not simply “Hydroxyapatite” but is a
defective and rather complex material doped with several mono- or divalent
cations (Na+, K+, Mg2+, Zn2+, Fe2+, etc. upto 1.3 wt.% ) as well as with CO32- (5.8
wt.%) and HPO42- ions with a generic formula of Ca8.3(PO4)4.3(HPO4, CO3)1.7(OH,
CO3)0.3. The FTIR pattern of bone mineral also shows the presence of CO32- and
HPO42-, in the coatings of this study. Henceforth, we will refer the apatitic
calcium phosphate coating as bone mineral-like apatite.
7.3.3 Microstructural Analysis
The pore sizes (200 to 300 µm) and the strut morphology of the asreceived collagen foams are shown in the FE-SEM micrographs (Fig. 7.3a, low
magnification and Fig. 7.3b, high magnification). The initial progress of the SBFcoating, as a function of soaking time was also studied via FE-SEM (Figs. 7.4a
and b). The low magnification (Fig. 7.4a) micrographs show that only a part of
the collagen surface is covered with bone mineral such as apatite after soaking in
t-SBF for 3 days. At higher magnifications, the globules of apatite become clearly

149

Fig. 7.3 FE-SEM micrographs of porous collagen prior to SBF soaking (a) low
and (b) high magnification.

Fig. 7.4 FE-SEM micrographs of collagen membrane soaked in t-SBF for a
period of 3 days; (a) the collagen surface not fully covered in 3 days, (b)
characteristic bone-mineral like apatite globules, (c) their attachment and
(d) nanoporous texture of these globules becomes readily visible.
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visible along with the underlying collagen fibrils (Fig. 7.4b). At this point, it is
hard to predict the nature of attachment of these globules with the collagen. It can
be either be a physically or chemically bonded attachment.
In the case of physical attachment, the precipitates that form in the SBF
loosely attach to the collagen surface. For chemically bonded attachments, there
should be an interaction between bone mineral-like apatite and collagen. Figure
7.4c shows a single globule attached to the surface of the collagen surface. In the
same figure, initial growth of SBF produced bone mineral like apatite is evident
on the collagen surface. Also, since the strip was floating near the top in the SBF
containing bottle, the chances of gravity driven segregation (produced in the SBF)
on the surface is minimized. This means that it cannot be a physical attachment
process, but a chemically bonded process instead. (Fig. 7.4d) shows a high
magnification micrograph of the same area. In this micrograph interlocked nanoneedle morphology is seen. A similar kind of morphology is also seen on other
materials (Ti, Ti6Al4V, calcium phosphates) when soaked in SBF.28 At this
magnification, we observed that the whole surface is not fully coated. Thus, we
conclude that we needed to increase the coatings time so that the whole surface is
coated fully and homogeneously.
Based on our observation, we increased the time period of soaking the
porous collagen membrane to 7 days. FE-SEM micrographs of Figure 7.5a and d
represent our results. The low magnification micrographs show that both the
upper struts of foams as well as those underneath are homogeneously coated (Fig.
7.5a and b). Since the gravity effects are minimized, the foams are coated on all
sides. This is somewhat different as opposed to coating heavier substrates such as
metals and ceramics. As we increased the time of soaking, the strips were fully
covered without clogging the pores with bone mineral-like apatite during the
coating process. Higher magnification micrographs (Fig. 7.5c and d) show that
there is no difference in morphology when the soaking time was increased from 3
to 7 days. Low magnifications showed the globules of apatite and the high
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Fig. 7.5 FE-SEM micrographs of collagen membrane soaked in t-SBF for a
period of 7 days; (a) full surface coverage was observed, (b) the pores
were not blocked, (c) the globules become clearly visible, and (d) these
globules have the nano-porous morphology.
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magnifications showed the nano-sized needles on these globules. Of particular
interest was the fact that the surface of the untreated collagen membrane initially
had micro-porosities, whereas after coating, the surface exhibited nano-porosities
formed by the interlocking of the nano-sized needles.
7.3.4

In Vitro Results
Results of in vitro examinations with mouse osteoblast are summarized by

the histograms in Figures 7.6a (Live/Dead cytotoxicity) and 7.6b (ALP activity).
When compared with untreated collagen membranes, the SBF coated collagen
resulted in an increase of attached cells and ALP activity. When viewed under
FE-SEM, the apatitic surfaces created by t-SBF solutions were found to be the
more viable surface for osteoblasts to attach and grow than the untreated collagen
surfaces. Figures 7.6c and d, represent untreated collagen foams, where the
osteoblasts were only able to attach and then extend their filopodia over the
available surface. Figures 7.6e and f represent osteoblast cell proliferation and
attachment on SBF-coated foams. As evident in these figures, osteoblast cells
were able to proliferate to the extent that even the vinculin adhesion plaques, the
actin cytoskeleton and the stress fibers became visible. The response of the
osteoblast to a given material is regarded as the sum of their ability to attach,
proliferate, and differentiate. In the attachment stage, osteoblast filopodia explore
the surface topography for areas to which a greater surface area of the cell can
adhere. The filopodia are used in sensing the substrate, and extend over
significant distances to find an appropriate area to attach. Osteoblast cells produce
fewer adhesion plaques while still in the process of migration.
7.4.

Discussion

To the best of our knowledge, coating of collagen by soaking in t-SBF has never
been performed. The collagen membrane was coated fully and homogeneously
with bone mineral-like apatite in 7 days. The coated strips were then compared
with the untreated strips in terms of osteoblast cell response. This discussion
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Fig. 7.6 In vitro (a) cell viability and (b) protein histograms for untreated and
SBF-coated (7 days) collagen; Osteoblast proliferation and attachment
on (c)-(d): untreated collagen membrane; (e)-(f): t-SBF coated collagen
(7 days).
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addresses the mechanisms of formation of carbonated apatitic calcium phosphates
and the effects of several coating parameters on its formation.
7.4.1

Formation of Bone Mineral-like Apatite in SBF Solution
The SBF solution has a Ca/P ratio similar to that of human plasma, 2.50.

Different chemical reagents are used to prepare different SBF solutions and
reagents used to prepare t-SBF are mentioned in Section 3.3.2 Table 3.1. Various
chemical reagents and their respective amounts have different effects on the
coating phase formed in the solution. The presence of 1mM Na2HPO4 along with
2.5 mM CaCl2.2H2O in the recipe helps in forming calcium phosphates. The
presence of 27mM NaHCO3 plays an important role and assists in the carbonating
the coatings. The pH of the solution is another criterion in predicting the phase
that will precipitate. If the pH of the solution is in the range of 5 to 6, then the
precipitating phase is dicalcium phosphate dihydrate37 and if the pH is 7.4 or
higher, then the solution nucleates carbonated apatitic calcium phosphates. This
means that the biomimetic coating process proceeds with the formation of
carbonated apatitic calcium phosphates. The precipitation of carbonated apatitic
calcium phosphates from the SBF solution may be described by the following
reaction38, 39:
(10-x-y)Ca2+ + (6-x-y)HPO42- + yHCO3- + 2H+ +2OH-

=

Ca10-x-y[(HPO4)x(CO3)y(PO4)6-x-y](OH)2-x + (8-x)H+
The PO42- sites of the calcium phosphates formed in the SBF solution are
substituted with HPO42- and CO32-. The carbonate ion doping into the phosphate
tetrahedral of apatitic calcium phosphates results in the creation of charge
compensating Ca- vacancies, which is the reason for the observed Ca-deficiencies
of calcium phosphates synthesized in SBF solutions. The addition of 112 mM
NaCl into SBF solution leads to the substitution of a certain fraction of Ca-sites
with monovalent Na+ ions. Because the nature of the precipitates formed does not
change with the addition of 5 mM K+ and/or 0.5 mM SO42- ions in the SBF
solution, the precipitates are similar to the bone mineral. As described earlier, the
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bone mineral consists of small sizes of biological apatite crystals containing
substantial amounts of 4 to 6 % CO32-, 0.5% Mg2+, 0.7% Na+, and is about 10%
Ca-deficient.1
7.4.2

Effect of HCO3- Ion Concentration on Coating Rate
As previously reported, various researchers attempted to coat collagen

substrates with bone mineral-like apatite using different SBF solutions.12-20, 32, 33
The SBF solutions used in the past have been c-12-20 and r-SBF32, 33. In this study,
successful coating of collagen membrane was performed by using t-SBF as shown
by SEM micrographs in Figure 7.5. Significant differences in the coating rates
were observed in the present research in comparison to those performed earlier. It
has been shown by various researchers that increasing the HCO3- ion
concentration in the SBF solution resulted in a much thicker and a homogeneous
carbonated apatitic calcium phosphate layer on substrates.28, 34 Since t-SBF has a
higher HCO3- concentration than c-SBF, faster coating rates are expected. By
using t-SBF we were able to establish homogeneous coatings on collagen surface.
It is also reported that r-SBF performed faster coating than c-SBF,28, 32 which is
due to the higher HCO3- concentration in r-SBF. Without any modification (being
done to either collagen or SBF), collagen was reportedly coated in 2 weeks when
soaked in r-SBF.32 Collagen, when soaked in c-SBF, even duration of 4 weeks did
not completely cover collagen.13 The present study reports the coating of collagen
by t-SBF in 7 days which is faster than the coatings formed by c-SBF. Thus, for
biomimetic coating processes the usage of t- and/or r-SBF over c-SBF is
preferable, since they have higher concentrations of HCO3-.
7.4.3

Effect of Buffering Agent on the Coating Morphology
Differences were also observed in the coating morphology of the apatitic

calcium phosphates of the present study with those reported earlier. t-SBF formed
round globules consisting of interlocking needle-like nanosize apatitic calcium
phosphates (Fig. 7.5c and d) which were similar to those formed by c-SBF12-20 as
reported in previous studies. Girija et al.32 used r-SBF for the coating of collagen
fibrils, the precipitates formed on collagen were nearly spherical aggregates and
clearly differed to those formed by c-SBF. These precipitates resembled those
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formed by Bigi-SBF26 (referred to as b-SBF), which is known as a HEPES-NaOH
buffered 27 mM HCO3- SBF solution. Similar morphological differences in the
coatings formed by the above-mentioned 3 SBF solutions on Ti6Al4V substrates
were reported in a recent study.28 This difference is possibly due to the different
buffers used in the composition of the SBF solutions. While TRIS-HCl buffer was
used in the preparation of c- and t-SBF solution, HEPES-NaOH buffer was used
for r-SBF preparation. Therefore, the buffer used in preparing a specific SBF
solution may have a significant influence on the morphology of the resultant
coatings. This could be related to the effect of buffers on the stability of SBF
solution which is explained in detail in the following paragraph.
7.4.4

Effect of Buffering Agent on the Stability of SBF Solution
The ionic strength of the SBF solution also plays a crucial role. c- and t-

SBF solutions have the same ionic strength values, that is, 160.5 mM whereas rSBF has a significantly lower value of 149.5 mM. CO2 is released from an
aqueous solution at a faster rate if the solution has a low ionic strength.40 The
release of CO2 from the SBF solution in turn leads to an increase in the pH
resulting in a decrease in the level of supersaturation of the solution. It was
observed that the pH increase in case of r-SBF solutions was higher than those
observed in t-SBF solutions. It is known that HEPES-NaOH buffered r-SBF is
unable to retain the HCO3- ions to the same extent as those in the TRIS-HCl
buffered t-SBF solutions. This conclusion is corroborated by other researchers
who emphasized that HEPES buffer was unstable and release CO2 from the
solution.28, 34, 35 Moreover, the pH of 7.4 is the lower end of the buffering capacity
of TRIS buffer and this facilitates the formation of calcium phosphate nuclei or
clusters in SBF solutions.41 As compared to that, HEPES buffer has an even lower
buffering capacity at a pH of 7.4.42-44 This explains the instability of the HEPESNaOH buffer and the r-SBF solutions. Moreover, the coatings deposited by t-SBF
solutions on Ti6Al4V substrates performed much better than those formed by cand r-SBF, when rat osteoblasts were cultured on them.28 Thus, from the view
point of coating stability, t-SBF was superior to r-SBF solution.
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7.4.5

In Vitro Osteoblast Response
Untreated collagen and SBF-coated collagen membranes were compared

via the alkaline phosphatase activity, cell density and cell proliferation tests by
using rat osteoblasts (7F2) (Fig. 7.6). Higher cell density (Fig. 7.6a) and alkaline
phosphatase activity (Fig. 7.6b) was observed for SBF-coated collagen
membranes. This study compares the response of osteoblasts to two parameters:
1) the nano-porous surface of the SBF coating and the original micro-porous
surface of the collagen membrane and 2) the chemistry of the materials, collagen
vs. apatitic calcium phosphates. Scientists have demonstrated that osteoblast
response is extremely sensitive to surface roughness and porosity.45 It has also
been previously reported that the proliferation numbers and alkaline phosphatase
(ALP) activities of the osteoblasts improved by approximately 30-40% when
comparing the smooth Thermanox control with the rougher calcium phosphate
coatings.46 In addition to differences in roughness, calcium phosphates differed in
chemical composition with Thermanox. This study also found that rat osteoblasts
were able to easily differentiate between the chemical composition of the surfaces
on which they were seeded. In other words, osteoblasts preferred the surface of
bone mineral-like apatite over the surface of pristine collagen membrane. It is a
well-known fact that the surface chemistry of a material determines the initial in
vitro interactions of proteins, such as fibronectin with integrin cell-binding
domains, which in turn regulate the cell adhesion process. A difference in the
osteoblast proliferation was also seen in the SEM micrographs (Fig. 7.6c, d, e and
f). The osteoblast spread well on the apatitic calcium phosphate coatings with
extending their filopodia and attaching to the nano-sized needles of the bone
mineral-like apatite (Fig. 7.6e and f). An overall improved response in terms of
osteoblast viability, ALP activity and proliferation was encountered on the
apatitic calcium phosphate coating (Fig. 7.6). Thus, the results show that the
apatite-coated collagen can be successfully employed as a scaffold material that
will prove useful in repairing bone defects.
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7.5.

Conclusions
Porous collagen membranes with interconnected pores were completely

coated biomimetically with apatitic calcium phosphates in 7 days by using 1.5x tSBF solution. This study reports a faster and a more efficient way to coat collagen
in comparison to the previous reported studies. SEM confirmed that the
biomimetic process was able to cover all the surfaces without clogging the pores.
XRD confirmed the nature of the apatitic nature of the coating and showed the
strong similarity of the coating to the bone mineral. FTIR corroborated the results
obtained by XRD, and showed the closeness in mimicking bone by the coatings.
In vitro cell culture tests with 7F2 rat osteoblasts were used to compare the
untreated collagen to the SBF-coated collagen membrane. The apatitic calcium
phosphates formed by the SBF soaking exhibited higher cell attachment and
alkaline phosphatase activity in comparison to the untreated collagen membrane.
Under SEM it was determined that the osteoblasts on SBF-coated surface were
more active and diffused more efficiently than the untreated collagen membrane.
7.6.
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